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Abstract  
 
Dietary nitrate (NO3-) supplementation, with NO3--rich beetroot juice (BR), 
increases nitric oxide (NO) bioavailability by the stepwise reduction of NO3- to 
nitrite (NO2-) and NO. This has been associated with a number of beneficial 
physiological and exercise performance effects, but understanding of NO3- 
metabolism is incomplete. The purpose of this thesis was to investigate some of 
the factors purported to influence dietary NO3- metabolism in humans. 
Specifically, the influence of oral cavity temperature and pH on dietary NO3- 
metabolism, and the influence of muscle oxygenation on exercise economy and 
tolerance were investigated following BR supplementation. Chapter 3: Salivary 
and plasma [NO3-] and [NO2-] were assessed at a neutral oral pH with a low 
(TempLo-pHNorm), intermediate (TempMid-pHNorm) and high (TempHi-pHNorm) oral 
temperature, and at an alkaline oral pH with a low (TempLo-pHHi), intermediate 
(TempMid-pHHi) and high (TempHi-pHHi) oral temperature. Compared to the 
TempMid-pHNorm trial (976 ± 388 µM), mean salivary [NO2-] over the protocol was 
higher in the TempMid-pHHi (1855 ± 423 µM), TempHi-pHNorm (1371 ± 653 µM), 
TempHi-pHHi (1792 ± 741 µM), TempLo-pHNorm (1495 ± 502 µM) and TempLo-
pHHi (2013 ± 662 µM) conditions, with salivary [NO2-] also higher at a given oral 
temperature when oral pH was increased (P<0.05). The increase in mean 
salivary [NO2-] was positively correlated with the increase in salivary flow rate 
when all data were combined (r = 0.48, P<0.01). Plasma [NO2-] was higher 3 
hours post BR consumption in the TempMid-pHHi, TempHi-pHHi and TempLo-pHHi 
trials, but not the TempLo-pHNorm and TempHi-pHNorm trials, compared to the 
TempMid-pHNorm trial (P<0.05). Chapter 4: Work-to-work step cycle tests were 
completed to exhaustion (Tlim) in normobaric hypoxia (fraction of inspired 
oxygen; FiO2: 15%), normoxia (FiO2: 21%) and hyperoxia (FiO2: 40%). Plasma 
[NO2-] was higher in all BR compared to all PL trials (P<0.05). Quadriceps 
tissue oxygenation index (TOI) was higher in normoxia compared to hypoxia 
(P<0.05) and higher in the hyperoxia compared to hypoxia and normoxia 
(P<0.05). Tlim was improved after BR compared to PL consumption (250 ± 44 
vs.  231 ± 41 sec), with the magnitude of improvement being negatively 
correlated with quadriceps TOI at exhaustion (r = -0.78), in hypoxia (P<0.05). 
Tlim tended to be improved with BR in normoxia (BR: 364 ± 98 vs.  PL: 344 ± 78 
sec; P=0.087), but was not improved in hyperoxia (BR: 492 ± 212 vs.  PL: 472 ± 
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196 sec; P>0.05). BR consumption increased peak oxygen uptake in hypoxia 
(P<0.05), but not normoxia or hyperoxia (P>0.05). Collectively, these findings 
improve our understanding of dietary NO3- metabolism and might help guide 
future studies assessing the efficacy of dietary NO3- supplementation on human 
health and performance. 
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Chapter 1: Introduction and Literature Review 
 
Nitric oxide  
 
Nitric oxide (NO) is a gaseous signalling molecule that was discovered as an 
‘endothelium-derived relaxing factor’ by Dr. Louis Ignarro, Dr. Robert Furchgott 
and Dr. Ferid Murad in the 1980’s. NO is best known for its vasodilatory function 
(Furchgott and Zawadzki, 1980; Ignarro et al., 1987; Murad et al., 1978) but it 
also influences numerous physiological processes including mitochondrial 
respiration (Ghafourifar and Cadenas, 2005) and biogenesis (Nisoli et al., 
2003), sarcoplasmic reticulum calcium handling (Viner, Williams and Schoneich, 
2000), neurotransmission (Garthwaite, 2008) and skeletal muscle glucose 
uptake (Merry, Lynch and McConnell, 2010) and fatigue (Percival et al., 2010). 
NO has a circulatory half-life of ~0.1 seconds (Kelm and Schrader, 1990). 
 
Nitric oxide production 
 
NO was initially considered to be exclusively synthesised from the oxidation of 
L-arginine by the NO synthase (NOS) enzymes (i.e. endothelial NOS, neuronal 
NOS and inducible NOS; Stamler and Meissner, 2001) in a complex metabolic 
reaction (the NOS pathway) that requires several additional substrates/co-
factors including O2, nicotinamide adenine dinucleotide phosphate, flavin 
adenine dinucleotide, flavin mononucleotide, tetrahydrobiopterin, haem and 
calmodulin (Alderton, Cooper and Knowles, 2001). The oxidation of NOS-
derived NO was known to produce nitrate (NO3-) and nitrite (NO2-); specifically, 
NO3- is synthesised from the reaction of NO2- or NO with oxyhaemoglobin 
(Cooper, 1999) and NO2- is synthesised from the reaction of NO with O2 
(Ignarro et al., 1993) or when NO is oxidised by ceruloplasmin (Shiva et al., 
2006). However, NO3- and NO2- were long considered inert by-products of NO 
metabolism (Moncada and Higgs, 1993).  
It is now known that NO3- and NO2- can be reduced into bioactive NO 
(the NO3--NO2--NO pathway; Lundberg et al., 2004; Lundberg and Weitzberg, 
2009). In addition to its endogenous synthesis, NO3- is naturally consumed as 
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part of the diet. ~80% of human dietary NO3- intake originates from vegetable 
sources (Gilchrist, Winyard and Benjamin, 2010; Hord, Tang and Bryan, 2009) 
with the remaining 20% derived from processed meats, where NO3- is used as a 
preservative, and drinking water. Vegetables with a ‘very high’ NO3- content 
(>250 mg/100 g fresh weight) include leafy greens (i.e. lettuce, spinach and 
rocket) and beetroot (Hord, Tang and Bryan, 2009). Following consumption, 
NO3- is rapidly absorbed in the stomach and small intestine (Florin, Neale and 
Cummings, 1990) and enters systemic circulation within ~60 min (Lundberg and 
Weitzberg, 2009) where it has a half-life of ~5 hr (McKnight et al., 1997). ~25% 
of the consumed NO3- is concentrated and secreted by the salivary glands 
(Lundberg and Weitzberg, 2009). This is then reduced to NO2- by commensal 
anaerobic bacteria located on the dorsal surface of the tongue, which contain 
the NO3- reductase enzymes required for NO2- production that humans lack 
(Duncan et al., 1995; Sasaki and Matano, 1979; Spiegelhalder, Eisenbrand and 
Preussmann, 1976). These enzymes have been suggested to have a high 
affinity for NO3-, with a maximum velocity (Vmax) of ~2 µmol of NO3-.mg-1.min-1 
and a Michaelis-Menten constant (KM; the substrate concentration that provides 
half of the enzymes Vmax) of <300 µM (Sparacino-Watkins, Stolz and Basu, 
2014). When swallowed, NO2- reacts with gastric acid in the stomach to form a 
mixture of nitrogen oxides, including NO (Benjamin et al., 1994; Duncan et al., 
1995). Alternatively, NO2- can be absorbed into circulation to increase plasma 
[NO2-]. Therefore, the reduction of NO2- to NO also occurs systemically (Zweier 
et al., 1995). This reaction can be catalysed by several enzymes including 
xanthine oxidase (Zhang et al., 1997), mitochondrial respiratory chain enzymes 
(Kozlov, Staniek and Nohl, 1999), cytochrome P-450 (Kozlov, Dietrich and Nohl, 
2003), deoxyhaemoglobin (Cosby et al., 2003; Nagababu et al., 2003), 
deoxymyoglobin (Shiva et al., 2007; Rassaf et al., 2007) and even NOS (Vanin 
et al., 2007). NO2- can also be reduced non-enzymatically in the presence of 
protons, which is greatly enhanced by reductants such as polyphenols (Peri et 
al., 2005) and vitamin C (Carlsson et al., 2001). The NO3--NO2--NO pathway 
has been proposed to represent a means of NO synthesis when the activity of 
the NOS pathway is impaired, such as conditions of low O2 availability (Bryan, 
2006), and has become a major focus of NO physiology research in recent 
years. 
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Dietary nitrate supplementation 
Plasma [nitrate] and [nitrite] 
 
Human plasma [NO3-] and [NO2-] is subject to notable inter-individual variability 
due to differences in age, health, training status and nutritional intake, however, 
typical resting values have been suggested to be ~34 µmol (Jungersten et al., 
1997) and ~305 nmol (Kleinbongard et al., 2003), respectively. Supplementing 
dietary NO3- intake with pharmacological (sodium NO3-; Larsen et al., 2007; 
2010) and natural (NO3--rich beetroot juice; BR; Bailey et al., 2009; 2010) 
means has been demonstrated to increase plasma [NO2-]. This thesis will focus 
on natural dietary NO3- supplementation with BR. 
Previous research has used a range of BR supplementation doses 
typically containing between 5.1 and 23 mmol NO3-. Wylie et al., (2013) 
investigated the dose-response relationship and pharmacokinetics and 
pharmacodynamics between acute BR supplementation (providing 4.2, 8.4 or 
16.8 mmol NO3-) and resting plasma [NO3-] and [NO2-]. Plasma [NO3-] was 
increased by 130, 282 and 580 µM, while plasma [NO2-] was increased by 150, 
291 and 425 nM, following 4.2, 8.4 and 16.8 mmol NO3- consumption, 
respectively. The peak change in plasma [NO3-] occurred 1 hour post-
consumption following 4.2 and 8.4 mmol NO3- and 2 hour post-consumption 
following 16.8 mmol NO3-, while the peak change in plasma [NO2-] occurred 2 
hour post-consumption following 4.2 and 8.4 mmol NO3- and 4 hour post-
consumption following 16.8 mmol NO3-. Collectively, these findings indicate that 
BR supplementation dose-dependently increases plasma [NO3-] and [NO2-] with 
the delayed peak increase in plasma [NO2-], compared to plasma [NO3-], 
presumably consequent to the time requirement for the enterosalivary 
circulation and reduction, by commensal anaerobic bacteria, of NO3- to NO2-.  
 
Physiological effects 
 Blood pressure 
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Three days of dietary NO3- supplementation with BR (providing 5.6 mmol.day-1 
NO3-) was demonstrated to reduce systolic blood pressure by ~5 mmHg in 
healthy young adults (Bailey et al., 2009). Subsequent research identified that 
this magnitude of change was evident following a single dose (providing 5.2 
mmol NO3-) and was maintained following both five and fifteen days of 
supplementation (Vanhatalo et al., 2010). The effect of BR supplementation on 
diastolic blood pressure appears to be less consistent, with results for (~4 
mmHg reduction; Vanhatalo et al., 2010) and against (no change; Bailey et al., 
2009) a reduction reported in normotensive participants. In hypertensive 
patients, four weeks of BR supplementation (providing 6.4 mmol.day-1 NO3-) 
was demonstrated to reduce systolic blood pressure by ~8 mmHg and diastolic 
blood pressure by ~2 mmHg (Kapil et al., 2015). Wylie et al., (2013) reported 
that systolic blood pressure was reduced dose dependently following acute BR 
supplementation providing 4.2 (~5 mmHg reduction) and 8.4 (~10 mmHg 
reduction) mmol NO3- with no additional benefit gained from the consumption of 
16.8 mmol NO3- (~9 mmHg reduction), while diastolic blood pressure was 
reduced equally following the consumption of 8.4 and 16.8 mmol NO3- (~3 
mmHg reduction) with no effect evident following the consumption of 4.2 mmol 
NO3-. The time to peak reduction in systolic and diastolic blood pressure (2-4 
hours) occurred after the time to peak plasma [NO3-] and [NO2-] (~2 hours) 
following BR supplementation providing 8.4 mmol NO3- (Wylie et al., 2013). 
Therefore, the beneficial haemodynamic effect of dietary NO3- supplementation 
is believed to be associated with the stepwise reduction of NO3- to NO2- and 
NO. NO stimulates smooth muscle relaxation by the synthesis of cyclic 
guanosine monophosphate (cGMP; Murad, 1986).  
 
Pulmonary and muscular oxygen uptake 
 
Dietary NO3- supplementation with BR has been demonstrated to reduce the O2 
cost of moderate-intensity exercise by ~5% in healthy young adults following 
acute (Vanahtalo et al., 2010) and chronic (Bailey et al., 2009; Vanahatalo et 
al., 2010) consumption. Wylie et al., (2013) reported that steady-state O2 uptake 
(V̇O2) was reduced dose-dependently following acute BR supplementation 
(providing 4.2, 8.4 or 16.8 mmol NO3-), with a peak reduction of ~50 ml.min-1. 
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NO has been suggested to alter steady-state V̇O2 by reducing the adenosine 
triphosphate (ATP) cost of skeletal muscle force production (Bailey et al., 2010; 
Fulford et al., 2013), increasing the oxidative phosphorylation efficiency of the 
mitochondria (Larsen et al., 2011) and/or improving muscle blood flow (Bailey et 
al., 2009; Ferguson et al., 2013). Bailey et al., (2009) reported an improved 
muscle oxygenation following BR supplementation via the observation of an 
increased [total haemoglobin] and [oxyhaemoglobin] at baseline and over the 
first 120 sec of exercise in the vastus lateralis muscle using single-channel near 
infrared spectroscopy. Furthermore, [deoxyhaemoglobin], an index of muscle 
fractional O2 extraction, was reduced by 13% during exercise following BR 
supplementation. The Fick equation denotes that for the same V̇O2, an 
increased O2 delivery enables a reduced muscle fractional O2 extraction. 
Therefore, the reduced V̇O2 following BR supplementation suggests that less O2 
extraction was required to sustain oxidative energy turnover during moderate-
intensity exercise. However, while BR supplementation has been reported to 
lower the O2 cost of sub-maximal exercise in health, recreationally active 
individuals, most studies conducted on well-trained athletes suggest it does not 
lower the O2 cost of sub-maximal exercise in this population (Bescós et al., 
2011; Carriker et al., 2016; Christensen, Nyberg and Bangsbo, 2013; Nyakayiru 
et al., 2017; Porcelli et al., 2015).  
 
Exercise tolerance and performance 
 
Previous research has demonstrated a ~15% improvement in continuous 
cycling (Bailey et al., 2009; Wylie et al., 2013) and running (Lansley et al., 
2011b) exercise tolerance following BR supplementation. This magnitude of 
improvement has been suggested to equate to a ~1-2% improvement in athletic 
performance when using an ecologically valid test, such as a cycling time trial 
(Paton and Hopkins, 2006), which would be extremely meaningful in 
competition. Subsequently, a ~3% improvement in 4 and 16.1 km time trial 
performance by club-level cyclists (mean V̇O2 peak = 56 ± 6 ml.kg body 
mass.min-1) was demonstrated following acute BR consumption (providing ~6.2 
mmol NO3-; Lansley et al., 2011a), while a ~1% improvement in 10 km time trial 
performance by well-trained cyclists (mean V̇O2 peak = 58 ± 2 ml.kg body 
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mass.min-1) was demonstrated following chronic BR supplementation (providing 
~8 mmol.day-1 NO3- for 6 days; Cermak, Gibala and van Loon, 2012). However, 
not all studies have demonstrated an improved exercise performance in well-
trained endurance athletes following BR supplementation (Lowings et al., 2017; 
McQuillan et al., 2016; Nyakayiru et al., 2017; Porcelli et al., 2015; Wilkerson et 
al., 2012). For example, Wilkerson et al., (2012) reported a non-significant 0.8% 
reduction in 50 mile time trial performance by well-trained cyclists (mean V̇O2 
peak = 63 ± 8 ml.kg body mass.min-1) following acute BR consumption (providing 
~6.2 mmol NO3-).  
 
Factors influencing dietary nitrate metabolism 
Oral cavity temperature and pH 
 
The reduction of NO3- to NO2- is a crucial limiting factor for dietary NO3- 
metabolism since humans lack the NO3- reductase enzymes required for NO2- 
production (Duncan et al., 1995; Lundberg et al., 2004). These enzymes are 
contained within commensal oral bacteria, which use NO3- as a terminal 
electron acceptor during anaerobic respiration (Duncan et al., 1995; Lundberg 
et al., 2004). Previous research has demonstrated that suppressing these oral 
bacteria attenuates the rise in salivary and plasma [NO2-] following BR 
supplementation (McDonagh et al., 2015; Woessner et al., 2016). The influence 
of facilitating the activity of the oral bacteria and the subsequent effect on 
salivary and plasma [NO2-] following dietary NO3- supplementation is currently 
unclear. Previous research has demonstrated a role for oral temperature and 
pH on [NO2-] following the incubation of NO3- solutions in the oral cavity, with 
optimal [NO2-] evident at a temperature attuned to a summer climate and a pH 
of 8 (Bojić, Bojić and Perović, 2004). The human oral cavity maintains a 
relatively constant temperature (34-36°C) and pH (~7; Marcotte and Lavoie, 
1998). Therefore, elevating these conditions might augment the increment in 
salivary and plasma [NO2-] observed following BR supplementation, but this 
remains to be determined.  
 
Muscle oxygenation 
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The reduction of NO2- to NO has been suggested to be facilitated under hypoxic 
conditions (Bryan, 2006) which might be evident in contracting skeletal muscle 
(Bailey et al., 2010; Richardson et al., 1999). This suggests a role for muscle 
oxygenation in the physiological effects induced by dietary NO3- 
supplementation, which might be greater in hypoxia (<21% oxygen; O2) and 
lower in hyperoxia (>21% O2) compared to normoxia (21% O2).  
 The reduced fraction of inspired O2 (FiO2) in hypoxic air decreases 
arterial O2 saturation and the intracellular partial pressure of O2 (PO2; 
Richardson et al., 1995). This stimulates local NO-mediated vasodilation to 
increase muscle blood flow and O2 supply (Casey et al., 2010). Compared to 
normoxia, sub-maximal constant work rate exercise in hypoxia is performed at 
the same V̇O2 but with greater muscle metabolic perturbation, consequent to 
greater utilisation of the anaerobic reserves (i.e. phosphocreatine and glycogen) 
to sustain the required rate of ATP turnover (Hogan, Richardson and Haseler, 
1999). The subsequent accumulation of fatigue-related metabolites (i.e. 
adenosine diphosphate, inorganic phosphate and hydrogen ions) contribute to 
an impaired exercise tolerance (Hogan, Richardson and Haseler, 1999). Dietary 
NO3- supplementation with BR has been demonstrated to reduce muscle 
metabolic perturbation (Vanhatalo et al., 2011), lower steady-state V̇O2 and 
speed V̇O2 kinetics (Kelly et al., 2014) and improve exercise tolerance (Kelly et 
al., 2014; Vanhatalo et al., 2011) in hypoxia, presumably due to an increased 
NO bioavailability.  
The increased FiO2 in hyperoxic air increases arterial O2 saturation and 
the intracellular PO2 (Collins et al., 2015) and has been associated with an 
improved sub-maximal (Adams and Welch, 1980) and maximal (Adams and 
Welch, 1980; Linossier et al., 2000) exercise capacity. This is likely mediated by 
an increased muscle V̇O2 (Astorino and Robergs, 2003) and greater 
maintenance of muscle contractile function (Linossier et al., 2000); mechanisms 
that are consistent with those induced by dietary NO3- supplementation in 
hypoxia. To date, no study has investigated the physiological effects induced by 
dietary NO3- supplementation during exercise in hyperoxia. However, a reduced 
time to fatigue was observed in mouse muscle fibres following incubation with 
sodium NO2- at a supra-physiological PO2 (Nogueira et al., 2013). Therefore, 
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exercise performed in hyperoxia might be associated with a reduced stimulus 
for NO2- reduction to NO, thus attenuating the physiological effects induced by 
dietary NO3- supplementation. However, this remains to be identified. 
 
Summary 
 
Dietary NO3- supplementation can elicit several physiological effects, 
presumably by increasing NO bioavailability. These effects include: a reduced 
systolic blood pressure (Bailey et al., 2009; Vanhatalo et al., 2010; Webb et al., 
2008; Wylie et al., 2013), due to an increased synthesis of cGMP (Murad, 
1986); a reduced O2 cost of moderate-intensity exercise (Bailey et al., 2009; 
Vanhatalo et al., 2010; Wylie et al., 2013), due to improvements in muscle 
contractile function (Bailey et al., 2010), mitochondrial efficiency (Larsen et al., 
2011) and/or muscle blood flow (Bailey et al., 2009; Ferguson et al., 2013); and 
an improved tolerance to severe-intensity exercise (Bailey et al., 2009; Wylie et 
al., 2013). These effects are believed to be NO-mediated. The synthesis of NO 
by NO3- metabolism is critically dependent on the reduction of NO3- to NO2- in 
the mouth and the subsequent reduction of NO2- to NO in the stomach or 
systemically. Manipulating oral cavity temperature and pH has been suggested 
to aid NO3- reduction to NO2- while lowering muscle oxygenation has been 
suggested to aid the reduction of NO2- to NO. Therefore, these factors have the 
potential to increase NO signalling after BR supplementation.  
 
Aims 
 
The purpose of this thesis is to investigate the effect of manipulating oral 
temperature and pH, and muscle oxygenation, on dietary NO3- metabolism.  
This thesis aims to enhance existing knowledge of the conditions that might 
influence the efficacy of dietary NO3- supplementation to improve exercise 
physiology and performance. The following research questions will be 
addressed:  
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1) Does the manipulation of oral cavity temperature and pH influence the 
effectiveness of BR supplementation at increasing NO bioavailability in 
humans? 
a. Does an alkaline oral cavity pH increase the effectiveness of BR 
supplementation at elevating salivary and plasma [NO2-]?  
b. Does an increased oral cavity temperature increase the 
effectiveness of BR supplementation at elevating salivary and 
plasma [NO2-]? 
c. Does the combination of an alkaline oral cavity pH and an 
increased oral cavity temperature exert a synergistic increase in 
salivary and plasma [NO2-]? 
 
2) Does altering the FiO2 influence the effectiveness of BR supplementation 
at improving the physiological responses and tolerance to exercise? 
a. Does BR supplementation reduce the O2 cost of moderate-
intensity exercise and enhance severe-intensity exercise tolerance 
in normoxia, as previously reported (Bailey et al., 2009).  
b. Does BR supplementation reverse the detrimental effects of 
hypoxia on the physiological responses and tolerance to exercise, 
as previously reported (Kelly et al., 2014).  
c. Does BR supplementation induce physiological responses and 
alter the tolerance to exercise in hyperoxia? 
 
Hypotheses 
 
The following hypotheses will be tested: 
1) Salivary and plasma [NO3-] and [NO2-] would be increased following BR 
supplementation, [NO2-] would be increased further when oral 
temperature and pH were elevated independently and the greatest [NO2-] 
would be achieved when oral temperature and pH were elevated 
simultaneously. 
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2) Following dietary NO3- supplementation, muscle oxygenation, V̇O2 
kinetics and exercise tolerance would be augmented in normoxia, 
increased further in hypoxia and attenuated in hyperoxia. 
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Chapter 2: General methods 
 
General experimental procedures  
Ethics and participant consent 
 
The two studies included in this thesis were approved by the University of 
Exeter’s Sport and Health Sciences Ethics Committee prior to the onset of data 
collection. Participants provided their written informed consent after reading the 
Participant Information Sheet, which described in detail the experimental 
protocol and their specific involvement, and having any questions about the 
study answered.  
 
Health and safety 
 
All experimental procedures were conducted in accordance with the Sport and 
Health Sciences Health and Safety Code of Practise 2015-16. The researchers 
were vigilant of laboratory cleanliness, safety and suitability for the testing of 
human participants.  
 
Participants  
 
The participants recruited for the studies in Chapters 3 and 4 were male 
University of Exeter students (mean ± SD; age = 23 ± 3 years, height = 1.80 ± 
0.06 m; body mass = 77.1 ± 9.4 kg). Participants were non-smokers and free 
from disease. No participant reported antibiotics use prior to the study or dietary 
supplement or antibacterial mouthwash use during the study. The effects of 
prior antibacterial mouthwash use on the oral microbiome would be transient, 
thus not likely to influence our findings. All participants were recreationally 
active but not highly trained. In both studies, participants were instructed to 
report to the laboratory in a rested and fully hydrated state, having not 
consumed food in the previous 3 hours, caffeine in the previous 12 hours or 
alcohol in the previous 24 hours. Strenuous exercise was to be avoided in the 
previous 24 hours. Experimental testing was performed at the same time of day 
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(±2 hours) for each participant to minimise the potential for diurnal variation to 
influence the results.  
 
Supplementation  
 
Dietary NO3- supplementation was administered in the form of BR, which was 
donated by James White Drinks (Ipswich, UK). In both studies, participants 
were instructed to consume either concentrated NO3--rich BR (providing ~6.2 
mmol NO3- per 70 ml) or concentrated NO3--depleted BR as a placebo (PL; 
providing negligible NO3- content) in a repeated measures, crossover 
experimental design. The [NO3-] of three BR supplements was measured 
directly to determine the accuracy of the data reported by the manufacturer 
(Jajja et al., 2014). Similar to the findings of Jajja and colleagues, mean [NO3-] 
(6.5 ± 0.7 mmol) differed from that reported by the manufacturer. The PL 
supplement was manufactured by filtering the BR through a column containing 
Purolite A520E ion exchange resin prior to pasteurisation, which selectively 
removes the NO3- ions (Lansley et al., 2011a; 2011b). This procedure creates a 
PL supplement that is identical to the test supplement in appearance, taste and 
smell.  
 In Chapter 3, the supplements were either concentrated BR (1 x 70 ml) 
or concentrated PL (1 x 70 ml). Participants were instructed to consume the test 
supplement at the beginning of the experimental protocol. A washout period of 
at least 24 hours separated each experimental visit. In Chapter 4, the 
supplements were either concentrated BR (3 x 70 ml) or concentrated PL (3 x 
70 ml). Participants were instructed to consume the test supplement 2.5 hours 
before the exercise test. A washout period of at least 48 hours separated each 
experimental visit (Lansley et al., 2011a; 2011b). In both chapters, participants 
were instructed to consume a NO3- and glucosinolate/thiocyante restricted diet 
throughout data collection and to replicate their dietary intake in the 24 hours 
prior to each experimental visit. The harmless, temporary side effects of BR 
consumption, including beeturia (red urine) and red stools, were communicated 
to participants.  
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Measurement procedures 
Descriptive data  
 
Prior to any experimental testing, each participant’s age was recorded and their 
height and mass were measured using a Seca Stadiometer SEC-225 (Seca, 
Hamburg, Germany) and Seca Digital Column Scale SEC-170 (Seca, Hamburg, 
Germany), respectively.  
 
Blood sample collection 
 
For the studies in chapters 3 and 4, a Insyte-W cannula (Becton-Dickinson, 
Madrid, Spain) was inserted into a forearm vein by a phlebotomy-trained 
individual. This allowed for multiple blood samples to be drawn efficiently during 
the subsequent protocol. In chapter 3, the cannula was kept clear with the 
infusion of 0.9% saline at a rate of 10 ml.h-1, which was administered with 
single-use 5 ml syringes (Terumo, Leuven, Belgium). 5 ml syringes were also 
used to draw the blood samples, following the removal of dead space content 
using a 2.5 ml single-use syringe (Terumo, Leuven, Belgium). The samples 
were immediately ejected into 5 ml Vacutainer lithium-heparin tubes (Becton-
Dickinson, New Jersey, USA) and were subsequently centrifuged at 4000 
revolutions per minute (rpm) and 4°C for 8 min. The plasma was then extracted 
and stored at -80°C for later analyses of NO3- and NO2-. 
 
Measurement of nitrate and nitrite concentrations 
 
The quantification of plasma [NO3-] and [NO2-] are technically challenging 
with considerable variability reported between the assays used. For example, 
the modified Griess reaction is an assay used frequently to measure [NO2-] 
(Tsikas, 2007). However, this method lacks the sensitivity to identify the 
nanomolar NO2- levels present in human plasma. Therefore, ozone-based 
chemiluminescence is considered the preferred assessment method (Higuchi 
and Motomizu, 1999). 
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All glassware, utensils and surfaces were regularly rinsed with deionised 
water to remove residual NO3- and NO2- before sample analyses. In chapter 3, 
plasma samples were deproteinized using zinc sulfate (ZnSO4)/sodium 
hydroxide (NaOH) precipitation prior to determination of [NO3-]. Firstly, 500 μL 
of 0.18 N NaOH was added to 100 µL of sample followed by 5 min incubation at 
room temperature. Subsequently, samples were treated with 300 μL aqueous 
ZnSO4 (5% w/v) and vortexed for 30 seconds before undergoing an additional 
10 min incubation period at room temperature. Samples were then centrifuged 
at 4,000 rpm for 5 min, and the supernatant was removed for subsequent 
analysis. The [NO3-] of the deproteinized plasma sample was determined by its 
reduction to NO in the presence of 0.8 % (w/v) vanadium chloride (VCl3) in 1 M 
hydrochloric acid (HCl) within an air-tight purging vessel. Plasma samples were 
introduced to the vessel via 50 uL injections into the septum at the top of the 
vessel. The spectral emission of electronically excited nitrogen dioxide, derived 
from the reaction of NO with ozone, was detected by a thermoelectrically 
cooled, red-sensitive photomultiplier tube housed in a Sievers NOA 280i gas-
phase chemiluminescence NO analyzer (Analytix, Durham, UK). The [NO3-] was 
determined by plotting signal (mV) area against a calibration plot of sodium 
NO3- standards. The [NO2-] of the undiluted (non-deproteinized) plasma was 
determined by its reduction to NO in the presence of glacial acetic acid and 
aqueous sodium iodide (NaI) (4% w/v) from sodium NO2- standards. 100 uL 
injections were used for plasma [NO2-] determination. After thawing at room 
temperature, saliva samples were centrifuged for 10 min at 14000 rpm and the 
supernatant was removed for subsequent analysis. The supernatant was diluted 
100-fold with deionized water and [NO3-] and [NO2-] were determined from 50 
uL injections using the same reagents described above for the plasma 
analyses. In chapter 4, plasma [NO2-] was determined using the same method 
as in chapter 3.  
 
Exercise testing  
 
In chapter 4, participants performed a cycle ramp incremental exercise test for 
the determination of their V̇O2 peak and gas exchange threshold (GET). All tests 
were performed on an Excalibur Sport cycle ergometer (Lode, Groningen, The 
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Netherlands). Participants were instructed to remain seated and maintain a 
pedal cadence of 80 rpm for as long as possible. The test began with a baseline 
stage of 20 W for 4 min. Following this, the workload was increased at a linear 
rate of 40 W.min-1 and continued until the participant reached volitional 
exhaustion or the pedal cadence fell below 70 rpm for five consecutive seconds. 
Breath-by-breath pulmonary gas exchange data were collected continuously 
throughout using a Medgraphics Cardiorespiratory Diagnostics (Express Series, 
Gloucester, UK). The data were then averaged over consecutive 10 sec time 
periods with V̇O2 peak determined as the highest 30 sec average value. GET was 
derived from test data using the cluster of measurements previously employed 
by Bailey et al., (2009). Briefly, GET was determined as the first: 
disproportionate increase in the volume of carbon dioxide (CO2) produced 
(V̇CO2), as determined by visual inspection of the individual data points of V̇O2 
plotted against V̇CO2; increase in expired ventilation (VE)/V̇O2 without an 
increase in VE/V̇CO2; increase in end-tidal O2 tension without a decline in end-
tidal CO2 tension. 
‘Work-to-work step’ cycle exercise tests were then used to assess 
moderate-intensity exercise economy and severe-intensity exercise tolerance 
(Breese et al., 2011). All tests were performed on an Excalibur Sport cycle 
ergometer (Lode, Groningen, The Netherlands). Each participant’s preferred 
saddle height and handle bar configuration was recorded and reproduced for 
subsequent tests. The test began with a baseline stage of 20 W for 3 min. 
Following this, immediate transitions were performed to 90% GET for 4 min and 
then 75% Δ (% difference between power output at the GET and V̇O2 peak) until 
volitional exhaustion. Breath-by-breath pulmonary gas exchange data were 
collected continuously throughout using a Medgraphics Cardiorespiratory 
Diagnostics (Express Series, Gloucester, UK). The work rates were calculated 
from the individual’s ramp test pulmonary gas exchange data, with 
consideration for the mean response time of V̇O2 during this mode of exercise 
(i.e. two-thirds of the ramp rate was subtracted from the power output value at 
GET and V̇O2 peak; Whipp et al., 1981). Exercise tolerance was represented by 
the time to exhaustion following the transition to 75% Δ (Bailey et al., 2009).  
 
Statistical methods 
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In chapters 3 and 4, all statistical analyses were performed using Statistical 
Package for Social Sciences version 23. The specific statistical analyses run in 
each study are outlined in their respective chapters. Prior to any analysis, data 
sets were screened for normality using appropriate procedures. Statistical 
significance was accepted at P<0.05. All data are presented as mean ± 
standard deviation unless otherwise stated.   
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Chapter 3: Influence of oral temperature and pH on dietary nitrate 
metabolism in healthy adults 
 
Abstract 
 
It has been reported that the reduction of nitrate (NO3-) to nitrite (NO2-) by oral 
NO3--reducing bacteria can be augmented by an increased oral temperature 
and pH. However, the independent and combined effect of increasing oral 
temperature and pH on dietary NO3- metabolism is unclear. This study tested 
the hypothesis that the elevated salivary and plasma [NO2-] observed following 
NO3- supplementation would be further enhanced by independently increasing 
oral temperature and pH, with a greater effect demonstrated by simultaneously 
increasing oral temperature and pH. Seven heathy adult males (mean ± SD, 
age 23 ± 4 yr, body mass 76 ± 11 kg) consumed 1 x 70 ml of beetroot juice 
concentrate (BR, providing ~6.5 mmol NO3-) on six separate laboratory visits. In 
a randomised crossover experimental design, salivary and plasma [NO3-] and 
[NO2-] were assessed at a neutral oral pH with a low (TempLo-pHNorm), 
intermediate (TempMid-pHNorm) and high (TempHi-pHNorm) oral temperature, and 
at an alkaline oral pH with a low (TempLo-pHHi), intermediate (TempMid-pHHi) and 
high (TempHi-pHHi) oral temperature. Compared to the TempMid-pHNorm trial (976 
± 388 µM), mean salivary [NO2-] over the protocol was higher in the TempMid-
pHHi (1855 ± 423 µM), TempHi-pHNorm (1371 ± 653 µM), TempHi-pHHi (1792 ± 
741 µM), TempLo-pHNorm (1495 ± 502 µM) and TempLo-pHHi (2013 ± 662 µM) 
conditions, with salivary [NO2-] also higher at a given oral temperature when 
oral pH was increased (P<0.05). The increase in mean salivary [NO2-] was 
positively correlated with the increase in salivary flow rate when all data were 
combined (r = 0.48, P<0.01). Plasma [NO2-] was higher 3 hours post BR 
consumption in the TempMid-pHHi, TempHi-pHHi and TempLo-pHHi trials, but not 
the TempLo-pHNorm and TempHi-pHNorm trials, compared to the TempMid-pHNorm 
trial (P<0.05). Therefore, despite consuming the same NO3- dose, the increases 
in salivary and plasma [NO2-] varied depending on the temperature and pH of 
the oral cavity. These findings might have implications for enhancing dietary 
NO3- metabolism and its potential beneficial effect on human health and 
performance. 
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Introduction 
 
Inorganic nitrate (NO3-) and nitrite (NO2-) have classically been viewed as inert 
end-products of nitric oxide (NO) metabolism. However, a substantial body of 
evidence has emerged over the last two decades indicating that NO3- and NO2- 
can be chemically reduced into bioactive NO (Lundberg et al., 2004; Lundberg 
and Weitzberg, 2009; 2010). Therefore, increasing dietary NO3- consumption 
might enhance NO production. Supplementation with natural NO3--rich beetroot 
juice (BR) has been demonstrated to increase salivary (McDonagh et al., 2015) 
and plasma (Bailey et al., 2009; 2010; McDonagh et al., 2015; Webb et al., 
2008) [NO2-]. This has been associated with the observation of NO-like 
physiological effects including reductions in resting blood pressure (Bailey et al., 
2009; McDonagh et al., 2015; Webb et al., 2008) and the oxygen cost of 
moderate-intensity exercise (Bailey et al., 2009). As such, considerable 
research interest has been generated regarding the therapeutic potential of 
dietary NO3- supplementation for the treatment of cardiovascular diseases 
(reviewed by Lundberg et al., 2011) as well as the ergogenic implications for 
physical performance (reviewed by Bailey et al., 2012).  
~80% of human dietary NO3- intake originates from vegetable sources 
including leafy greens and beetroot (Gilchrist et al., 2010; Hord et al., 2009). 
Following consumption, NO3- is rapidly absorbed in the stomach and small 
intestine (Florin et al., 1990) and enters systemic circulation within ~60 minutes 
(Lundberg and Weitzberg, 2009). The salivary glands concentrate and secrete 
~25% of the ingested NO3- (Lundberg and Weitzberg, 2009), which is then 
reduced to NO2- by commensal bacteria located on the dorsal surface of the 
tongue (Duncan et al., 1995; Sasaki and Matano, 1979; Spiegelhalder et al., 
1976). When swallowed, NO2- reacts with gastric acid in the stomach to form a 
mixture of nitrogen oxides including NO (Benjamin et al., 1994; Duncan et al., 
1995).  
The reduction of NO3- to NO2- is a crucial limiting factor for dietary NO3- 
metabolism because humans lack the NO3- reductase enzymes required for 
NO2- production (Duncan et al., 1995; Lundberg et al., 2004). Commensal oral 
bacteria, such as the Veillonella genus (Doel et al., 2005; Hyde et al., 2014), 
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contain these enzymes and use NO3- as a terminal electron acceptor during 
anaerobic respiration (Duncan et al., 1995; Lundberg et al., 2004). This 
promotes a symbiotic relationship between the bacteria and its host; one that is 
characterised by the reduction of NO3- to NO2-. Importantly, the use of 
antibacterial mouthwash abolishes the oral microbiota, thus attenuating the rise 
in salivary and plasma [NO2-] following BR supplementation (McDonagh et al., 
2015; Woessner et al., 2016). Conversely, NO2- production, following the 
incubation of NO3- solutions in the oral cavity, was facilitated by increments in 
temperature and pH with peak bioconversion occurring at a temperature 
attuned to a summer climate and a pH of 8 (Bojić, Bojić and Perović, 2004; Xu, 
Xu and Verstraete, 2000). Considering that the human oral cavity maintains a 
relatively constant temperature (34-36°C) and pH (~7; Marcotte and Lavoie, 
1998), it might be possible for NO2- production following BR supplementation to 
be altered by manipulating these conditions. To date, no study has investigated 
the reduction of NO3- to NO2- following dietary NO3- supplementation and 
changes in oral temperature and pH. Increased salivary [NO3-] after dietary NO3- 
consumption might enhance NO production and its associated health and 
performance benefits.  
 The purpose of this study was to investigate how changes in oral 
temperature and pH influence the ability of acute BR supplementation to 
increase salivary and plasma [NO2-] in humans. It was hypothesised that: 1) 
salivary and plasma [NO3-] and [NO2-] would increase following BR 
supplementation; 2) salivary and plasma [NO2-] would be increased further 
when oral temperature and pH were elevated independently; and 3) a greater 
salivary and plasma [NO2-] would be achieved when oral temperature and pH 
were elevated simultaneously.  
 
Methods 
 
Seven healthy adult males (mean ± SD; age = 23 ± 4 years, height = 1.79 ± 
0.06 m, body mass = 75.7 ± 10.5 kg) volunteered to participate in this 
experiment. Participants were all non-smokers and were not current users of 
any medication. Each participant was familiarised with the laboratory testing 
protocol prior to data collection. The procedures received ethical approval from 
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the Institutional Research Ethics Committee. Written informed consent was 
obtained prior to any involvement in the experiment and following detailed 
explanations of the procedures, associated risks and potential benefits. For 
each visit, participants were instructed to report to the laboratory in a rested and 
fully hydrated state, having not consumed food in the previous 3 hours, caffeine 
in the previous 12 hours or alcohol in the previous 24 hours. Strenuous exercise 
was also avoided in the 24 hours preceding each visit. Participants kept a food 
diary in the 24 hours preceding their first experimental visit, avoiding foods high 
in dietary NO3- and glucosinolate/thiocyanate, and replicated this consumption 
in the 24 hours prior to their subsequent visits. The use of antibacterial 
mouthwash was prohibited to preserve the commensal bacteria in the oral 
cavity (Govoni et al., 2008). All experimental visits were performed in an air-
conditioned laboratory (20°C) at the same time of day (±2 hours) to minimise 
the influence of diurnal biological variation. 
 
Experimental design 
 
Participants reported to the laboratory on seven occasions over a 4-7 week 
period. The first visit was used to familiarise the individual with the experimental 
testing procedures including venous cannulation, saliva sampling, oral 
temperature assessment and mouth rinse administration. The experimental 
conditions were completed on visits two to seven. On each occasion a single 
dose (1 x 70 ml) of NO3--rich BR concentrate (Beet it, James White Drinks, 
Ipswich, UK), containing ~6.5 mmol NO3-, was consumed and the temperature 
and pH of the oral cavity were manipulated to assess the effect of these 
variables on dietary NO3- metabolism. Temperature of the oral cavity was 
manipulated using a combination of breathing techniques, hot water bottles 
and/or gel packs. The three temperature conditions were: 1) ‘low’, which 
consisted of breathing through the mouth (TempLo); 2) ‘intermediate’, which 
consisted of breathing through the nose with the mouth closed (TempMid); and 
3) ‘high’, which consisted of breathing though the nose with the mouth closed 
while wearing two fleeced, hot water bottles, containing boiling water, applied 
anti-parallel around the neck and a heated gel pack (Reliance Medical, 
Cheshire, UK) strapped to the left cheek (TempHi). Specifically, the apex of the 
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inferior hot water bottle was in contact with the posterior surface of the neck 
while the apex of the superior hot water bottle was in contact with the anterior 
surface of the neck and the upper surface rested on the submandibular space. 
The gel pack was heated for 45 sec in a microwave oven immediately prior to 
application. pH of the oral cavity was manipulated using mouth rinses. Here, 30 
ml of either neutral (tap water; pH 7.3 ± 0.1; pHNorm) or alkaline (tap water 
titrated using food-grade sodium bicarbonate; 500 ml water to 10 g sodium 
bicarbonate; pH 8.1 ± 0.1; pHHi) test solution was swilled for 2 min before being 
fully expectorated. Therefore, the six experimental conditions were: 1) 
intermediate oral temperature, neutral oral pH (TempMid-pHNorm); 2) intermediate 
oral temperature, high oral pH (TempMid-pHHi); 3) high oral temperature, neutral 
oral pH (TempHi-pHNorm); 4) high oral temperature, high oral pH (TempHi-pHHi); 
5) low oral temperature, neutral oral pH (TempLo-pHNorm); and 6) low oral 
temperature, high oral pH (TempLo-pHHi). A test order was assigned using a 
randomised crossover design and each visit was separated by at least 24 
hours.  
 
Procedures 
 
Upon arrival at the laboratory, participants were provided with a standardised, 
low dietary NO3- and glucosinolate/thiocyanate, breakfast consisting of 54 g of 
Oats So Simple porridge oats (Quaker Oats, Chicago, USA), prepared with 180 
ml of tap water, and one 20 g sachet of Lyle’s Golden Syrup (Tate & Lyle, 
London, UK). Following this, an Insyte-W cannula (Becton-Dickinson, Madrid, 
Spain) was inserted into a forearm vein by a phlebotomy-trained individual and 
was kept clear with the infusion of 0.9% saline at a rate of 10 ml.h-1 for the 
duration of the protocol. The baseline blood sample was then drawn (see 
Measurements). Subsequently, baseline oral temperature was recorded (see 
Measurements) for 10 min with participants breathing through their nose with a 
closed mouth. The baseline saliva sample was collected (see Measurements) 
during the last 2 min of the baseline oral temperature measurement. The 
temperature manipulation was then applied with the hot water bottles/gel packs 
replaced every 30 min in the TempHi-pHNorm and TempHi-pHHi trials to maintain 
the elevated oral temperature. The temperature probe was removed after 5 min 
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with subsequent measurements taken for 5.5 min every 30 min. The first mouth 
rinse was then performed with subsequent rinses occurring every 7.5 min. Pilot 
testing revealed this to be the required frequency of rinsing to maintain the 
elevated oral pH. The test supplement was then consumed and each hour, for 
the next 3 hours, a blood and saliva sample were collected. At the 2:30 hour 
mark, the time taken for peak NO3- reduction following BR consumption (Wylie 
et al., 2013), the temperature and pH manipulations ceased.  
 
Measurements 
 
Venous blood samples (~5 ml) were drawn into lithium-heparin tubes (Becton-
Dickinson, New Jersey, USA) and immediately centrifuged at 4000 rpm and 4°C 
for 10 min. Following this, the plasma was extracted and stored at -80°C for 
later analysis of [NO3-] and [NO2-] (see below). For the collection of whole, 
unstimulated, saliva samples, participants first swallowed their saliva content 
and then drooled into a sample tube until the base was full (~1.2 ml). The 
sample was immediately analysed for temperature and pH, using a SI series pH 
meter (Sentron, Leek, The Netherlands), and volume, using a S1 Pipet Filler 
and serological pipette (Thermo Scientific, Massachusetts, USA), before 
storage at -80°C for later analyses of [NO3-] and [NO2-] (see below). Oral 
temperature was measured by placing a temperature probe (Carefusion, Illinois, 
USA) under the tongue. The probe was connected to a Squirrel SQ2020 Series 
Data Logger (Grant, Cambridgeshire, UK), which captured data at 0.33 Hz. 
Upon completion of each mouth rinse, the solution was fully expectorated and 
the volume of the mixture was recorded to provide an indication of how much 
NO2--rich saliva had been lost. In the TempMid-pHNorm and TempMid-pHHi trials, 
mouth rinses were heated to 35.0 ± 1.2 °C to maintain oral temperature, 
whereas mouth rinses were administered at room temperature (20.7 ± 0.1 °C) in 
the TempLo-pHNorm and TempLo-pHHi trials to lower oral temperature, and heated 
to 40.4 ± 0.7 °C to increase oral temperature in the TempHi-pHNorm and TempHi-
pHHi trials. 
 All glassware, utensils and surfaces were rinsed with deionised water to 
remove residual NO3- and NO2- before sample analyses. Plasma samples were 
deproteinized using zinc sulfate (ZnSO4)/sodium hydroxide (NaOH) 
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precipitation prior to determination of [NO3-]. Firstly, 500 μL of 0.18 N NaOH 
was added to 100 µL of sample followed by 5 min incubation at room 
temperature. Subsequently, samples were treated with 300 μL aqueous ZnSO4 
(5% w/v) and vortexed for 30 seconds before undergoing an additional 10 min 
incubation period at room temperature. Samples were then centrifuged at 4,000 
rpm for 5 min, and the supernatant was removed for subsequent analysis. The 
[NO3-] of the deproteinized plasma sample was determined by its reduction to 
NO in the presence of 0.8 % (w/v) vanadium chloride (VCl3) in 1 M hydrochloric 
acid (HCl) within an air-tight purging vessel. Plasma samples were introduced to 
the vessel via 50 uL injections into the septum at the top of the vessel. The 
spectral emission of electronically excited nitrogen dioxide, derived from the 
reaction of NO with ozone, was detected by a thermoelectrically cooled, red-
sensitive photomultiplier tube housed in a Sievers NOA 280i gas-phase 
chemiluminescence nitric oxide analyzer (Analytix, Durham, UK). The [NO3-] 
was determined by plotting signal (mV) area against a calibration plot of sodium 
nitrate standards. The [NO2-] of the undiluted (non-deproteinized) plasma was 
determined by its reduction to NO in the presence of glacial acetic acid and 
aqueous sodium iodide (NaI) (4% w/v) from sodium nitrite standards. 100 uL 
injections were used for plasma [NO2-] determination. After thawing at room 
temperature, saliva samples were centrifuged for 10 min at 14000 rpm and the 
supernatant was removed for subsequent analysis. The supernatant was diluted 
100-fold with deionized water and [NO3-] and [NO2-] were determined from 50 
uL injections using the same reagents described above for the plasma 
analyses. 
 
Data analysis  
 
Oral temperature at each time point was taken as the mean temperature over 
the final 5 min of the recording. Data for oral temperature were then analysed 
as a condition mean, which was taken as the mean temperature of all time 
points. Data for salivary pH was analysed as the mean salivary pH between the 
baseline, 1 and 2 hours post BR consumption samples. Salivary flow rate was 
calculated by dividing the volume added to the mouth rinse solutions by the 
collection time, based on the procedure used by Walsh et al., (2004).  
37 
 
 
Statistical analysis 
 
A two-way (condition × time) repeated measures ANOVA was used to 
determine the independent and combined effects of manipulating oral 
temperature and pH on salivary and plasma [NO3-] and [NO2-]. A one-way 
repeated measures ANOVA was used to determine the effects of oral 
temperature and pH manipulation on the mean salivary and plasma [NO3-] and 
[NO2-], oral temperature, salivary pH and salivary flow rate across the 
experimental conditions. Where the analysis revealed a significant main or 
interaction effect, Fishers Least Significant Difference tests were used to 
determine the origin of such effects. Pearson’s product moment correlation 
coefficient was used to assess the relationship between changes in variables 
across conditions. Statistical analyses were performed using SPSS version 23.0 
(IBM, Chicago, USA) with significance set at P<0.05. All results are presented 
as means ± SD unless stated otherwise. 
 
Results 
 
Self-reported compliance to the avoidance of potential confounding factors (i.e. 
restricting dietary intake of NO3- and glucosinolate/thiocyanate and not using 
antibacterial mouthwash) was 100%. BR consumption was well tolerated by all 
participants with only minor, non-harmful side effects, including beeturia (red 
urine) and red stools, reported. This is consistent with previous studies using a 
similar dose of BR consumption (Bailey et al., 2009; Wylie et al., 2013).  
 
Oral temperature 
 
The influence of BR consumption and oral temperature and pH manipulation on 
oral temperature is presented in Figure 1. There was a main effect for condition 
on oral temperature (P<0.01). Oral temperature was higher in the TempMid-
pHNorm and TempMid-pHHi trials compared to the TempLo-pHNorm and TempLo-
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pHHi trials, and higher in the TempHi-pHNorm and TempHi-pHHi trials compared to 
the TempMid-pHNorm, TempMid-pHHi, TempLo-pHNorm and TempLo-pHHi trials 
(P<0.01 for all comparisons).  
 
 
Figure 1. Oral temperature (upper panel) and salivary pH (lower panel) after acute nitrate-rich 
beetroot juice consumption in intermediate temperature-neutral pH (TempMid-pHNorm), 
intermediate temperature-high pH (TempMid-pHHi), high temperature-neutral pH (TempHi-pHNorm), 
high temperature-high pH (TempHi-pHHi), low temperature-neutral pH (TempLo-pHNorm) and low 
temperature-high pH (TempLo-pHHi) conditions. The oral temperature and salivary pH data are 
expressed as the mean response of all samples collected during the oral temperature and pH 
manipulations. The filled bars represent the group mean ± SEM responses while the solid grey 
lines represent the individual responses in each experimental condition. * indicates higher than 
TempLo-pHNorm and TempLo-pHHi (P<0.05). # indicates higher than TempMid-pHNorm, TempMid-
pHHi, TempLo-pHNorm and TempLo-pHHi (P<0.05). ¥ indicates higher than TempMid-pHNorm, TempHi-
pHNorm and TempLo-pHNorm (P<0.05). 
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Salivary pH 
 
The influence of BR consumption and oral temperature and pH manipulation on 
salivary pH is presented in Figure 1. There was a main effect for condition on 
salivary pH (P<0.01). Salivary pH was higher in TempMid-pHHi, TempHi-pHHi and 
TempLo-pHHi trials compared to the TempMid-pHNorm, TempHi-pHNorm and TempLo-
pHNorm trials (P<0.01 for all comparisons).  
 
Salivary flow rate 
 
The influence of BR consumption and oral temperature and pH manipulation on 
salivary flow rate is presented in Figure 2. There was a main effect for condition 
on salivary flow rate (P<0.05). Salivary flow rate was higher in the TempHi-pHHi 
trial than the TempHi-pHNorm trial (P<0.05), higher in the TempLo-pHHi trial than 
the TempMid-pHNorm, TempMid-pHHi, TempHi-pHNorm and TempLo-pHNorm trials 
(P<0.05) and tended to be higher in the TempLo-pHHi trial than the TempHi-pHHi 
trial (P=0.086).    
 
 
Figure 2. Salivary flow rate after acute nitrate-rich beetroot juice consumption in intermediate 
temperature-neutral pH (TempMid-pHNorm), intermediate temperature-high pH (TempMid-pHHi), 
high temperature-neutral pH (TempHi-pHNorm), high temperature-high pH (TempHi-pHHi), low 
temperature-neutral pH (TempLo-pHNorm) and low temperature-high pH (TempLo-pHHi) conditions. 
The data are expressed as the mean response of all samples collected during the oral 
temperature and pH manipulations. The filled bars represent the group mean ± SEM responses 
while the solid grey lines represent the individual responses in each experimental condition. * 
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indicates higher than TempHi-pHNorm (P<0.05). # indicates higher than TempMid-pHNorm, TempMid-
pHHi, TempHi-pHNorm and TempLo-pHNorm (P<0.05). 
 
Salivary [nitrate] 
 
The influence of BR consumption and oral temperature and pH manipulation on 
absolute salivary [NO3-] at baseline and 1, 2 and 3 hours post BR consumption, 
and mean salivary [NO3-] 1-3 hours post BR consumption, are presented in 
Figure 3. There was a main effect for time (P<0.001) with absolute salivary 
[NO3-] increasing above baseline in all experimental conditions. Absolute 
salivary [NO3-] was lower in the TempMid-pHHi trial compared to the TempHi-
pHNorm, TempHi-pHHi and TempLo-pHNorm trials 1 hour following BR consumption 
(P<0.05). The mean salivary [NO3-] 1-3 hours post BR consumption was also 
lower in the TempMid-pHHi trial compared to the TempHi-pHNorm, TempHi-pHHi and 
TempLo-pHNorm trials (P<0.05). 
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Figure 3. Salivary nitrate concentration ([NO3-]) across the protocol (upper panel) and the mean 
salivary [NO3-] at hours 1-3 of the protocol (lower panel) after acute NO3--rich beetroot juice 
consumption in intermediate temperature-neutral pH (TempMid-pHNorm), intermediate 
temperature-high pH (TempMid-pHHi), high temperature-neutral pH (TempHi-pHNorm), high 
temperature-high pH (TempHi-pHHi), low temperature-neutral pH (TempLo-pHNorm) and low 
temperature-high pH (TempLo-pHLo) conditions.  Salivary [NO3-] values across the protocol 
(upper panel) are expressed as group mean values with error bars omitted for clarity. The filled 
bars represent the group mean ± SEM responses while the solid grey lines represent the 
individual responses in each experimental condition for mean salivary [NO3-] at hours 1-3 of the 
protocol (lower panel). * indicates TempMid-pHHi lower than TempHi-pHNorm, TempHi-pHHi and 
TempLo-pHNorm (P<0.05). 
 
Salivary [nitrite] 
 
The influence of BR consumption and oral temperature and pH manipulation on 
absolute salivary [NO2-] at baseline and 1, 2 and 3 hours post BR consumption, 
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and mean salivary [NO2-] 1-3 hours post BR consumption, are presented in 
Figure 4. There were main effects for time (P<0.001) and condition (P<0.01), as 
well as a condition × time interaction effect (P<0.05), with absolute salivary 
[NO2-] increasing above baseline in all experimental conditions. Absolute 
salivary [NO2-] was higher 1 and 2 hours post BR consumption in the TempMid-
pHHi, TempHi-pHHi, TempLo-pHNorm and TempLo-pHHi trials compared to the 
TempMid-pHNorm trial (P<0.05), and higher than the TempMid-pHNorm trial in all 
other experimental conditions 3 hours post BR consumption (P<0.05). There 
was a main effect for condition on the mean salivary [NO2-] 1-3 hours post BR 
consumption (P<0.01) with mean salivary [NO2-] higher than the TempMid-pHNorm 
trial in all other experimental conditions (P<0.05), higher than the TempHi-pHNorm 
trial in the TempHi-pHHi and TempLo-pHHi trials (P<0.05) and higher than the 
TempLo-pHNorm trial in the TempLo-pHHi trial (P<0.05). When all data were 
pooled, salivary flow rate was positively correlated with the absolute salivary 
[NO2-] 1 hour (r = 0.32, P<0.05), 2 hours (r = 0.5, P<0.01) and 3 hours (r = 0.47, 
P<0.01) post BR consumption, and the mean salivary [NO2-] 1-3 hours post BR 
consumption (r = 0.48, P<0.01). 
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Figure 4. Salivary nitrite concentration ([NO2-]) across the protocol (upper panel) and the mean 
salivary [NO2-] at hours 1-3 of the protocol (lower panel) after acute nitrate-rich beetroot juice 
consumption in intermediate temperature-neutral pH (TempMidm-pHNorm), intermediate 
temperature-high pH (TempMid-pHHi), high temperature-neutral pH (TempHi-pHNorm), high 
temperature-high pH (TempHi-pHHi), low temperature-neutral pH (TempLo-pHNorm) and low 
temperature-high pH (TempLo-pHLo) conditions.  Salivary [NO2-] values across the protocol 
(upper panel) are expressed as group mean values with error bars omitted for clarity. The filled 
bars represent the group mean ± SEM responses while the solid grey lines represent the 
individual responses in each experimental condition for mean salivary [NO2-] at hours 1-3 of the 
protocol (lower panel). * indicates TempMid-pHNorm lower than TempMid-pHHi, TempHi-pHHi, 
TempLo-pHNorm and TempLo-pHHi (P<0.05). # indicates TempMid-pHNorm lower than TempMid-pHHi, 
TempHi-pHNorm, TempHi-pHHi, TempLo-pHNorm and TempLo-pHHi (P<0.05). ɸ indicates lower than 
TempHi-pHHi and TempLo-pHHi (P<0.05). ¥ indicates lower than TempLo-pHHi (P<0.05). 
 
Plasma [nitrate] 
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The influence of BR consumption and oral temperature and pH manipulation on 
absolute plasma [NO3-] at baseline and 1, 2 and 3 hours post BR consumption, 
and mean plasma [NO3-] 1-3 hours post BR consumption, are presented in 
Figure 5.  There was a main effect for time (P<0.001) with absolute plasma 
[NO3-] increasing above baseline in all experimental conditions. There were no 
between condition differences in absolute plasma [NO3-] at 1, 2 and 3 hours 
post BR consumption or the mean plasma [NO3-] 1-3 hours post BR 
consumption (P>0.05). 
 
 
Figure 5. Plasma nitrate concentration ([NO3-]) across the protocol (upper panel) and the mean 
plasma [NO3-] at hours 1-3 of the protocol (lower panel) after acute NO3--rich beetroot juice 
consumption in intermediate temperature-neutral pH (TempMid-pHNorm), intermediate 
temperature-high pH (TempMid-pHHi), high temperature-neutral pH (TempHi-pHNorm), high 
temperature-high pH (TempHi-pHHi), low temperature-neutral pH (TempLo-pHNorm) and low 
temperature and pH (TempLo-pHLo) conditions.  Plasma [NO3-] values across the protocol (upper 
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panel) are expressed as group mean values with error bars omitted for clarity. The filled bars 
represent the group mean ± SEM responses while the solid grey lines represent the individual 
responses in each experimental condition for mean plasma [NO3-] at hours 1-3 of the protocol 
(lower panel). 
 
Plasma [nitrite] 
 
The influence of BR consumption and oral temperature and pH manipulation on 
absolute plasma [NO2-] at baseline and 1, 2 and 3 hours post BR consumption, 
and mean plasma [NO2-] 1-3 hours post BR consumption, are presented in 
Figure 6.  There were main effects for time (P<0.001) and condition (P<0.05), 
with absolute plasma [NO2-] increasing above baseline in all experimental 
conditions. Absolute plasma [NO2-] was higher 3 hours post BR consumption in 
the TempMid-pHHi, TempHi-pHHi and TempLo-pHHi trials compared to the TempMid-
pHNorm trial (P<0.05). There was a main effect for condition on the mean plasma 
[NO2-] 1-3 hours post BR consumption (P<0.01) with mean plasma [NO2-] higher 
than the TempMid-pHNorm in the TempHi-pHHi trial (P<0.05).     
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Figure 6. Plasma nitrite concentration ([NO2-]) across the protocol (upper panel) and the mean 
plasma [NO2-] at hours 1-3 of the protocol (lower panel) after acute nitrate-rich beetroot juice 
consumption in intermediate temperature-neutral pH (TempMid-pHNorm), intermediate 
temperature-high pH (TempMid-pHHi), high temperature-neutral pH (TempHi-pHNorm), high 
temperature-high pH (TempHi-pHHi), low temperature-neutral pH (TempLo-pHNorm) and low 
temperature and pH (TempLo-pHLo) conditions.  Plasma [NO2-] values across the protocol (upper 
panel) are expressed as group mean values with error bars omitted for clarity. The filled bars 
represent the group mean ± SEM responses while the solid grey lines represent the individual 
responses in each experimental condition for mean plasma [NO2-] at hours 1-3 of the protocol 
(lower panel). * indicates TempMid-pHNorm lower than TempMid-pHHi, TempHi-pHHi, and TempLo-
pHHi (P<0.05). # indicates lower than TempHi-pHHi (P<0.05).    
 
Discussion  
 
This is the first study to investigate how changes in oral temperature and pH 
influence the ability of BR supplementation to increase salivary and plasma 
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[NO2-]. Salivary and plasma [NO3-] and [NO2-] were all increased following BR 
supplementation, but the main novel findings from this study were that salivary 
[NO2-] was increased further when oral temperature and pH were manipulated 
with the peak increase evident when oral temperature was lowered and oral pH 
was elevated. Plasma [NO2-] was higher 3 hours post BR consumption in the 
alkaline pH conditions compared to the TempMid-pHNorm trial. These findings 
indicate that salivary and plasma [NO2-] following dietary NO3- consumption can 
be influenced by oral temperature and pH manipulation which might have 
implications for the physiological effects induced by dietary NO3- 
supplementation.    
 
Oral temperature and pH 
 
The experimental manipulations impacted upon oral temperature and pH. Mean 
oral temperature in the high, intermediate and low temperature conditions was 
36.2 ± 0.3°C, 34.9 ± 1.2°C and 33.6 ± 1.7°C, respectively, while mean salivary 
pH in the alkaline and neutral pH conditions was 7.8 ± 0.2 and 6.7 ± 0.2, 
respectively. An increased oral temperature and pH has previously been 
suggested to elevate NO3- reduction to NO2-, with a pH of ~8 demonstrated to 
be optimal (Bojić, Bojić and Pervović, 2004). Therefore, the salivary pH of 7.8 in 
the alkaline conditions might allow for an optimal salivary [NO2-] following 
dietary NO3- supplementation with BR.  
 
Salivary flow rate 
 
NO3- metabolism might be influenced by changes in salivary flow rate. An 
increased salivary flow rate would be expected to elevate NO3- secretion by the 
salivary glands thus providing more substrate for reduction to NO2-. This might 
increase salivary [NO2-]. Simultaneous, but not independent, oral temperature 
and pH manipulation impacted upon salivary flow rate, which was greater in the 
alkaline pH condition for both the high (TempHi-pHHi: 723 ± 261 µL.min-1 vs. 
TempHi-pHNorm: 501 ± 300 µL.min-1) and low (TempLo-pHHi: 1051 ± 543 µL.min-1 
vs. TempLo-pHNorm: 689 ± 584 µL.min-1) temperature conditions and tended to 
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be greater in the TempLo-pHHi trial compared to the TempHi-pHHi trial (Δ = 329 ± 
282 µL.min-1). Therefore, salivary [NO2-] following dietary NO3- consumption and 
oral temperature and pH manipulation might vary due to the differences elicited 
in salivary flow rate. The measurement of salivary flow rate, in the present 
study, builds upon previous research that did not account for this factor when 
investigating oral NO3- reduction to NO2- following temperature and pH 
manipulations (Bojić, Bojić and Pervović, 2004).  
 
Salivary and plasma [nitrate] and [nitrite] 
 
Consistent with previous research, BR supplementation increased salivary 
[NO3-] and [NO2-] (McDonagh et al., 2015; Woessner et al., 2016) and plasma 
[NO3-] (McDonagh et al., 2015; Wylie et al., 2013) and [NO2-] (Bailey et al., 
2009; 2010; Vanhatalo et al., 2010; 2011; Webb et al., 2008; Wylie et al., 2013). 
Salivary [NO3-] increased 26.8-, 17.6- and 11.8-fold, salivary [NO2-] increased 
12.6-, 8.8- and 8.6-fold, plasma [NO3-] increased 5.1-, 5.1- and 4.6-fold and 
plasma [NO2-] increased 0.8-, 1.5- and 1.6-fold at hours 1-3 post consumption in 
the TempMid-pHNorm trial, respectively. The magnitudes of change in plasma 
[NO3-] and [NO2-] conform with the dose-dependent elevations reported 
following acute BR supplementation by Wylie et al., (2013). The delayed time to 
peak plasma [NO2-] highlights the importance of dietary NO3- on the 
enterosalivary circuit and, therefore, the metabolism of NO3- by commensal oral 
bacteria (Duncan et al., 1995; Sasaki and Matano, 1979; Spiegelhalder et al., 
1976).  
 Following BR consumption, oral temperature and pH manipulation had 
no effect on salivary [NO3-] but salivary [NO2-] was increased further in the 
independently (TempMid-pHHi: Δ = 1076 ± 423 nM; 90%; TempHi-pHNorm: Δ = 592 
± 653 nM; 41%) and simultaneously (TempHi-pHHi: Δ = 1012 ± 741 nM; 84%) 
elevated oral temperature and pH conditions and in the low oral temperature 
conditions (TempLo-pHNorm: Δ = 715 ± 502 nM; 53% TempLo-pHHi: Δ = 1234 ± 
662 nM; 106%) compared to the TempMid-pHNorm trial. Plasma [NO3-] also 
remained unaltered following BR consumption and the experimental 
manipulations, however plasma [NO2-] was increased further than the TempMid-
pHNorm trial in the independently elevated oral pH condition (TempMid-pHHi: Δ = 
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192 ± 89 nM; 20%), the simultaneously elevated oral temperature and pH 
condition (TempHi-pHHi: Δ = 246 ± 75 nM; 53%) and in the TempLo-pHHi trial (Δ = 
220 ± 71 nM; 37%). Therefore, despite consuming the same NO3- dose, the 
increases in salivary and plasma [NO2-] varied depending on the temperature 
and pH of the oral cavity. The greatest increase in salivary [NO2-] was observed 
in the TempLo-pHHi trial. This is likely due to salivary flow rate, which was 
positively correlated with salivary [NO2-] (r = 0.48). Despite the larger salivary 
[NO2-] in the TempLo-pHHi trial, the greatest increase in plasma [NO2-] occurred 
in the TempHi-pHHi trial. It is plausible that this measurement was confounded 
by the mouth rinse protocol, which resulted in 46% more NO2--rich saliva being 
expectorated following the mouth rinses and sample collections in the TempLo-
pHHi trial compared to the TempHi-pHHi trial. This would likely impair the 
characteristic rise in plasma [NO2-] demonstrated following dietary NO3- 
supplementation (Lundberg and Govoni, 2004; Webb et al., 2008). Furthermore, 
the oral temperature manipulation might have elevated core temperature, which 
is known to increase eNOS activity and NO release (Harris et al., 2003). This 
would be expected to increase plasma [NO2-] independently of dietary NO3- 
metabolism. A limitation of the present study is that core temperature was not 
measured. Future research should build upon these limitations when 
administering oral temperature and pH manipulations following dietary NO3- 
supplementation.  
The results herein build upon previous research that demonstrated an 
increased [NO2-] following both NO3- consumption and oral pH manipulation 
using a pH-regulating chewing gum (van Maanen, van Geel and Kleinjans, 
1996) and the incubation of an alkaline NO3- test solution in the mouth (Bojić, 
Bojić and Pervović, 2004). Collectively, the findings suggest that NO3- reductase 
activity in the human oral cavity is sensitive to pH, salivary flow rate and, to a 
lesser extent, temperature. It is important to note that seasonal variations in oral 
cavity NO3- reductase activity has the potential to confound these findings. This 
might have influenced the results reported by Bojić, Bojić and Pervović (2004) 
due to their experimental manipulations being performed outdoors in a summer 
and winter climate. In the present study, the experimental manipulations were 
performed in a temperature-controlled laboratory during the winter and spring 
months, therefore, reducing this factor. Oral temperature and pH manipulation 
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following dietary NO3- supplementation might have implications for future BR 
supplementation recommendations, might contribute to understanding of the 
underlying physiology for responders and non-responders to dietary NO3- 
supplementation, and might enhance the cardiovascular health and physical 
performance benefits demonstrated at a given dietary NO3- dose. Therefore, 
further research is warranted.  
 
Conclusion 
 
The increase in salivary and plasma [NO2-] following acute BR supplementation 
was influenced by oral temperature and pH manipulation. Peak salivary [NO2-] 
was evident in the low oral temperature and alkaline oral pH condition, with the 
prior suggesting a key role for salivary flow rate in human NO3- metabolism. 
Plasma [NO2-] was also higher in the alkaline oral pH conditions. These results 
extend our understanding of dietary NO3- metabolism following BR 
supplementation. Further research is required to build upon the findings of this 
study. Specifically, investigating the impact of oral temperature and pH 
manipulation on plasma [NO2-] and the physiological effects induced by dietary 
NO3- supplementation might be fruitful areas of study.  
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Chapter 4: Effect of dietary nitrate supplementation on oxygen uptake 
kinetics and exercise tolerance: influence of muscle oxygenation 
 
Abstract 
 
We tested the hypothesis that dietary nitrate (NO3-) supplementation would 
improve muscle oxygenation, oxygen uptake (V̇O2) kinetics and exercise 
tolerance (Tlim) in normoxia and that these improvements would be augmented 
in hypoxia and attenuated in hyperoxia. In a randomized, cross-over study, ten 
healthy males completed work-to-work step cycle tests to exhaustion following 
acute consumption of 3 x 70 ml NO3--rich beetroot juice (BR; 19.5 mmol NO3-) 
or NO3--depleted beetroot juice placebo (PL; 0.12 mmol NO3-). These tests were 
completed in normobaric hypoxia (FiO2: 15%), normoxia (FiO2: 21%) and 
hyperoxia (FiO2: 40%). Pulmonary V̇O2 and quadriceps tissue oxygenation 
index (TOI), derived from multi-channel near-infrared spectroscopy, were 
measured during all trials. Plasma [nitrite] was higher in all BR compared to all 
PL trials (P<0.05). Quadriceps TOI was higher in normoxia compared to 
hypoxia (P<0.05) and higher in the hyperoxia compared to hypoxia and 
normoxia (P<0.05). Tlim was improved after BR compared to PL consumption 
(250 ± 44 vs.  231 ± 41 sec), with the magnitude of improvement being 
negatively correlated with quadriceps TOI at exhaustion (r = -0.78), in hypoxia 
(P<0.05). Tlim tended to be improved with BR in normoxia (BR: 364 ± 98 vs.  PL: 
344 ± 78 s; P=0.087), but was not improved in hyperoxia (BR: 492 ± 212 vs.  
PL: 472 ± 196 s; P>0.05). BR consumption increased peak V̇O2 in hypoxia 
(P<0.05), but not normoxia or hyperoxia (P>0.05). Therefore, NO3- 
supplementation is more likely to improve T lim and peak V̇O2 as skeletal 
muscles become increasingly hypoxic. 
 
Introduction  
 
Nitric oxide (NO) is a gaseous signalling molecule with physiological 
functions including the regulation of blood flow, muscle contractility and 
mitochondrial respiration (Stamler and Meissner, 2001). NO is endogenously 
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synthesised from the oxidation of L-arginine by the NO synthase (NOS) 
enzymes (the NOS pathway; Stamler and Meissner, 2001) or from the stepwise 
reduction of inorganic nitrate (NO3-) to nitrite (NO2-) and NO (the NO3--NO2--NO 
pathway; Lundberg et al., 2004; Lundberg and Weitzberg, 2009). NO3- is 
consumed as part of the human diet, with ~80% of its intake originating from 
vegetable sources including leafy greens and beetroot (Gilchrist et al., 2010; 
Hord et al., 2009). ~25% of the consumed NO3- is concentrated and secreted by 
the salivary glands (Lundberg and Weitzberg, 2009), which is then reduced to 
NO2- by commensal anaerobic bacteria located on the dorsal surface of the 
tongue (Duncan et al., 1995; Sasaki and Matano, 1979; Spiegelhalder et al., 
1976). When swallowed, NO2- reacts with gastric acid in the stomach to form a 
mixture of nitrogen oxides, including NO (Benjamin et al., 1994; Duncan et al., 
1995). Alternatively, NO2- can be absorbed into circulation where its reduction to 
NO is catalysed by several enzymes (i.e. xanthine oxidase; Zhang et al., 1998) 
or reduced non-enzymatically in the presence of protons (Carlsson et al., 2001; 
Peri et al., 2005). The NO3--NO2--NO pathway has been proposed to represent 
a means of NO synthesis when the activity of the NOS pathway is impaired, 
such as conditions of low oxygen (O2) availability (Bryan et al., 2006) which 
might be evident in contracting skeletal muscle (Bailey et al., 2010; Richardson 
et al., 1999), and has become a major focus of NO physiology research in 
recent years.   
An abundance of evidence exists to support the use of dietary NO3- 
supplementation, including NO3--rich beetroot juice (BR), to increase plasma 
[NO2-] (Bailey et al., 2009; 2010; Vanhatalo et al., 2010; 2011; Webb et al., 
2008; Wylie et al., 2013). This has been associated with lower pulmonary O2 
uptake (V̇O2; Bailey et al., 2009; Vanhatalo et al., 2010; Wylie et al., 2013) and 
greater indexes of vastus lateralis muscle oxygenation during moderate-
intensity exercise (Bailey et al., 2009) and an enhanced tolerance to severe-
intensity exercise (Bailey et al., 2009; Wylie et al., 2013) in healthy young adults 
performing in conditions of normal O2 availability (~21% O2; normoxia). These 
changes have been suggested to be caused by NO-mediated improvements in 
muscle contractile function (Bailey et al., 2010), mitochondrial efficiency (Larsen 
et al., 2011) and/or muscle blood flow (Ferguson et al., 2013) and might be 
more pronounced in conditions of reduced O2 availability (<21% O2; hypoxia) 
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whereby local NO-mediated vasodilation increases muscle blood flow to restore 
sufficient O2 supply (Casey et al., 2010). Indeed, BR supplementation has been 
shown to lower steady-state V̇O2 and speed V̇O2 kinetics during moderate-
intensity exercise and enhance severe-intensity exercise tolerance in hypoxia 
(Kelly et al., 2014). To date, no study has investigated the physiological and 
tolerance changes induced by dietary NO3- supplementation during exercise 
completed in conditions of increased O2 availability (>21% O2; hyperoxia). 
However, a reduced time to fatigue was observed in mouse muscle fibres 
following incubation with sodium NO2- at a supra-physiological partial pressure 
of O2 (PO2; Nogueira et al., 2013). Considering that the increased fraction of 
inspired oxygen (FiO2) in hyperoxic air is associated with a greater intracellular 
PO2 (Collins et al., 2015), exercise performed in hyperoxia might be associated 
with a reduced stimulus for NO2- reduction to NO, thus attenuating the 
physiological effects induced by dietary NO3- supplementation. However, this 
remains to be identified.  
The dietary NO3- supplementation studies by Bailey et al., (2009) and 
Kelly et al., (2014) used single-channel near infrared spectroscopy (NIRS) 
systems to measure the muscle oxygenation status of the vastus lateralis. The 
use of a multi-channel system, that comprises multiple source/detector pairings, 
would enable the investigation of regional differences within a single muscle 
(i.e. proximal vs. distal) and/or wider differences within a muscle group (i.e. 
vastus lateralis vs. rectus femoris within the quadriceps muscle group). To date, 
no study has used a multi-channel NIRS system to investigate the changes in 
quadriceps muscle group oxygenation induced by dietary NO3- supplementation 
and exercise in hypoxia, normoxia or hyperoxia.  
The purpose of this study was to investigate how dietary NO3- 
supplementation influenced muscle oxygenation, V̇O2 kinetics and exercise 
tolerance in hypoxia, normoxia and hyperoxia. Specifically, the alterations in 
plasma [NO2-], arterial SpO2, multi-channel NIRS-derived quadriceps TOI, 
pulmonary V̇O2 and time to exhaustion (Tlim) were investigated following acute 
BR supplementation and work-to-work step cycling exercise in hypoxia, 
normoxia and hyperoxia. It was hypothesised that muscle oxygenation, V̇O2 
kinetics and exercise tolerance would be augmented in normoxia, increased 
further in hypoxia and attenuated in hyperoxia following BR supplementation.  
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Methods 
 
Ten healthy males (mean ± SD; age = 23 ± 3 years, height = 1.80 ± 0.07 m, 
body mass = 78.2 ± 8.9 kg) volunteered to participate in this study. None of the 
participants were tobacco smokers or users of any medication. All participants 
were fully familiarised with the laboratory testing protocol prior to data collection. 
The procedures received ethical approval from the Institutional Research Ethics 
Committee. Written informed consent was obtained prior to data collection and 
following detailed explanations of the experimental procedures, associated risks 
and potential benefits of participation. For each visit, participants were 
instructed to arrive at the laboratory in a rested and fully hydrated state, 3 hours 
post-prandial, having not consumed caffeine in the previous 12 hours or alcohol 
in the previous 24 hours. Strenuous exercise was also avoided in the 24 hours 
preceding each visit. Each participant performed their experimental visits at the 
same time of day (±2 hours) to minimise the influence of diurnal biological 
variation on physiological responses and exercise performance. The use of 
antibacterial mouthwash was prohibited to preserve the NO3--reducing 
commensal oral bacteria (Woessner et al., 2016). Participants recorded their 
food intake in the 24 hours preceding their first experimental visit, avoiding 
foods high in dietary NO3- and glucosinolate/thiocyante, and replicated this 
consumption in the 24 hours preceding each subsequent visit.  
 
Experimental design 
 
Participants reported to the laboratory on nine occasions over a 3 to 5 week 
period. Following an initial ramp incremental exercise test and familiarisation 
trials, participants completed work-to-work step cycle exercise tests for the 
determination of plasma [NO2-] and V̇O2 kinetics, quadriceps oxygenation and 
exercise tolerance. The experimental trials were completed after acute 
consumption of either NO3--rich beetroot juice concentrate (BR; Beet it, James 
White Drinks, Ipswich, UK) or NO3--depleted beetroot juice concentrate as a 
placebo (PL; Beet it, James White Drinks, Ipswich, UK) in normobaric hypoxia 
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(BR-Hypo, PL-Hypo), normoxia (BR-Norm, PL-Norm) and hyperoxia (BR-Hyper, 
PL-Hyper). These conditions were administered double blind in a randomised 
crossover experimental design.  
 
Procedures  
 
During the first visit to the laboratory, a ramp incremental exercise test was 
performed for the determination of V̇O2 peak and gas exchange threshold (GET). 
All exercise tests were performed on an electrically-braked cycle ergometer 
(Lode Excalibur Sport, Groningen, The Netherlands). Following a baseline cycle 
at 20 W for 3 min, the work rate was increased at a linear rate of 40 W.min-1 
until the limit of tolerance. Participants cycled at a self-selected cadence 
(between 70-90 rpm) and this pedal rate along with saddle and handle bar 
configuration was recorded and reproduced in subsequent tests. Breath-by-
breath pulmonary gas exchange data were collected continuously during the 
incremental tests and subsequently averaged over consecutive 10 sec periods 
using a Medgraphics Cardiorespiratory Diagnostics (Express Series, 
Gloucester, UK). V̇O2 peak was determined as the highest 30 sec average value 
achieved before the participant’s volitional exhaustion. The GET was 
determined from a cluster of measurements including: 1) the first 
disproportionate increase in carbon dioxide (CO2) production (V̇CO2) from visual 
inspection of individual plots of V̇CO2 vs. V̇O2; 2) an increase in expired 
ventilation (V̇E) /V̇O2 with no increase in V̇E /V̇CO2; and 3) an increase in end-
tidal O2 tension with no fall in end-tidal CO2 tension. The data collected during 
the incremental test was used to calculate the work rates which were employed 
during the subsequent work-to-work step tests. Specifically, the work rates that 
would require 95% of the V̇O2 at GET (moderate-intensity exercise) and 75% of 
the difference between the V̇O2 at the GET and V̇O2peak (75% Δ; severe-
intensity exercise) were calculated, with consideration for the mean response 
time of V̇O2 during incremental ramp exercise (i.e. two-thirds of the ramp rate 
was subtracted from the power output at the GET and V̇O2 peak; Whipp et al., 
1981).  
Participants completed a work-to-work step exercise test in each of the 
remaining eight visits. Visits two and three were used to familiarise participants 
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with the exercise test while breathing normoxic and hypoxic inspirates, 
respectively. The experimental conditions were then completed on visits four to 
nine. Upon arrival at the laboratory, a Insyte-W cannula (Becton-Dickinson, 
Madrid, Spain) was inserted into a forearm vein, by a phlebotomy-trained 
individual, to enable the collection of frequent blood samples during and 
immediately after the exercise test. The participant was then transferred to the 
cycle ergometer where the mouthpiece, fingertip pulse oximeter and three sets 
of NIRS probes were fitted (see Measurements section below). Subsequently, 
participants underwent a 5 min seated rest while breathing the test specific 
inspirate (see Inspirate Generation section below) immediately followed by the 
work-to-work exercise test. The test began with 2 min of low-intensity ‘baseline’ 
cycling at 20 W before an abrupt transition to a moderate-intensity constant 
work rate equivalent to 95% GET (U → M). Following 4 min of moderate-
intensity cycling, the work rate was abruptly increased to a severe-intensity 
constant work rate equivalent to 75% Δ (M → S). The severe-intensity exercise 
bout was continued until the limit of tolerance, which was recorded when the 
pedal rate fell 10 rpm below the previously established self-selected cadence.  
Participants were required to consume 3 x 70 ml beetroot juice 
concentrate 2.5 hours prior to arrival at the laboratory for all experimental tests. 
BR (which provided ~19.5 mmol NO3-) was consumed for the BR-Norm, BR-
Hypo and BR-Hyper trials while PL (which provided ~0.1 mmol NO3-) was 
consumed for the PL-Norm, PL-Hypo and PL-Hyper trials (Wylie et al., 2013). 
Each experimental test was separated by a washout period of at least 48 hours 
(Lansley et al., 2011). 
 
Inspirate generation 
 
The test inspirates administered in this study were generated using an Altitude 
Air Generator 12 (Colorado Altitude Training, Louisville, USA). The generator 
comprised two outlets, one which expelled O2-enriched air and one which 
expelled O2-depleted air. Air from these outlets were delivered, via an extension 
conduit, to a 1000 L Douglas Bag (Cranlea & Co., Birmingham, UK), which 
acted as a reservoir and mixing chamber. To generate the hypoxic and 
hyperoxic inspirates, the O2-enriched and O2-depleted air was mixed until the 
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required O2 percentage was achieved. To generate the normoxic inspirate, the 
O2-enriched and O2-depleted air was delivered to the Dougas Bag in equal 
parts. The O2 and CO2 concentration of the inspirate was recorded prior to each 
test using a 5200 High Accuracy Paramagnetic O2 and CO2 Analyser 
(Servomex, Crowborough, UK). This analyser was calibrated prior to each test 
with a 16.0% O2, 8.0% CO2 and 76.0% nitrogen gas mix (BOC Special Gases, 
Guildford, UK). The mean O2 % in the PL-Norm, BR-Norm, PL-Hypo, BR-Hypo, 
PL-Hyper and BR-Hyper trials was 21.0 ± 0.2, 21.0 ± 0.1, 14.9 ± 0.1, 14.9 ± 0.1, 
40.1 ± 0.1 and 40.0 ± 0.1, respectively. The Douglas bag comprised a separate 
outlet tube that connected to a two-way breathing valve system (Cranlea, 
Birmingham, UK). The two-way valve was connected to the mouthpiece which 
provided a constant, unidirectional flow rate and ensured that no re-breathing of 
expired air occurred.  
 
Measurements 
 
Venous blood samples were collected at the end of unloaded and moderate-
intensity cycling, 120 sec following the onset of severe-intensity cycling and at 
the point of exhaustion during severe-intensity cycling. Samples (~5 ml) were 
drawn into lithium-heparin tubes (Becton-Dickinson, New Jersey, USA) and 
immediately centrifuged at 4000 rpm and 4°C for 10 min, within 2 min of 
collection. The plasma was subsequently extracted and immediately stored at -
80°C for later analyses of [NO2-] via ozone-based chemiluminescence, as used 
previously (Wylie et al., 2013).  
Arterial O2 saturation (SpO2) was measured continuously at 0.5 Hz using 
a Rad-87 pulse oximeter (Masimo, Irvine, USA) attached to the right index 
finger with the data file exported for later analysis. Quadriceps tissue 
oxygenation index (TOI) was measured continuously at three sites using two 
spatially-resolved NIRS systems with data sampled at 1 Hz. The TOI of the 
rectus femoris was assessed using a NIRO 200 tissue oxygenation 
spectrometer (Hamamatsu Photonics KK, Hamamatsu City, Japan) while the 
TOI of the vastus lateralis was assessed using a NIRO 200NX tissue 
oxygenation spectrometer (Hamamatsu Photonics KK, Hamamatsu City, 
Japan). Both systems comprised an emission probe that irradiated laser beams 
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and a detection probe. Three different wavelength laser diodes provided the 
light source (775, 810 and 850 nm in the NIRO 200 and 735, 810 and 850 in the 
NIRO 200NX) and the light returning from the tissue was detected by a 
photomultiplier tube in the spectrometer. The optodes were placed in a holder, 
which was secured to the skin with adhesive. The rectus femoris probe was 
placed at 50% of the distance between the patella and the greater trochanter. 
The proximal vastus lateralis probe was attached at 70%, with the distal vastus 
lateralis probe attached at 30%, of the distance between the patella and the 
greater trochanter. To secure the holder and wires in place, an elastic bandage 
was wrapped around the subject’s leg. The wrap helped to minimize the 
possibility that extraneous light could influence the signal and also ensured that 
the optodes did not move during exercise. Indelible pen marks were made 
around the holder to enable precise reproduction of the placement in 
subsequent tests. The inter-optode distance (3 cm) and optical pathlength factor 
(18.6 cm) were consistent between measurement sites.   
During all exercise tests, pulmonary gas exchange and ventilation were 
measured continuously using a Medgraphics CPX Express stress testing 
system (MGC Diagnostics, Saint Paul, USA). Participants wore a nose clip and 
breathed through a low-dead-space, low-resistance mouthpiece and preVent 
pneumotach flowmeter assembly (MGC Diagnostics, Saint Paul, USA). The 
inspired and expired gas volume and gas concentration signals were 
continuously sampled, the latter using galvanic (O2) and non-dispersive infrared 
(CO2) analysers (MGC Diagnostics, Saint Paul, USA) via a capillary line 
connected to the mouthpiece. The gas analysers were calibrated before each 
test with gases of known concentration and the turbine volume transducer was 
calibrated with a 3 L syringe (Hans Rudolph, Kansas City, USA).   
 
Data analysis  
 
The breath-by-breath V̇O2 data from each trial were initially examined to 
exclude errant breaths caused by coughing, swallowing, sighing, etc., and those 
values lying more than four standard deviations from the local mean were 
removed. The breath-by-breath data were subsequently linearly interpolated to 
provide second-by-second values and time-aligned to the start of exercise. A 
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single-exponential model without time delay, with the fitting window 
commencing at t = 0 sec (equivalent to the mean response time, MRT) was 
used to characterise the kinetics of the overall V̇O2 response during the U→M 
and M→S step work rate increments as described in the following equation:  
 
V̇O2 (t) = V̇O2 baseline + A (1-e- (t/MRT))    (Eqn. 1)                                          
 
where V̇O2 (t) represents the absolute V̇O2 at a given time; V̇O2 baseline 
represents the mean V̇O2 measured over the final 60 sec of baseline; and A and 
MRT represent the amplitude and MRT, respectively, describing the overall 
increase in V̇O2 above baseline. An iterative process was used to minimise the 
sum of the squared errors between the fitted function and the observed values. 
We quantified the V̇O2 MRT with the fitting window constrained to the end of the 
U→M work rate increment and to 180 sec of the M→S work rate increment. The 
absolute V̇O2 at the end (mean over the final 60 sec) of the U→M and M→S 
work rate increments, and at 180 sec (± 15 sec) of M→S were also calculated, 
as was the change (∆) in V̇O2 between baseline and end-exercise in the U→M 
and M→S work rate increments and between baseline and 180 sec of the M→S 
work rate increment.     
The TOI responses at the rectus femoris and proximal and distal vastus 
lateralis were averaged prior to analysis. The absolute TOI at the end (mean 
over the final 60 sec) of the unloaded baseline, the U→M and M→S work rate 
increments, and at 180 sec (± 15 sec) during the M→S work rate increment 
were subsequently calculated. The SpO2 data from the start of unloaded cycling 
up to 120 sec of severe-intensity cycling exercise were averaged for each 
experimental condition to provide an overall SpO2 profile for each trial.  
 
Statistical analysis  
 
A two-way, supplement (PL and BR) × inspirate (hypoxia, normoxia and 
hyperoxia), repeated-measures ANOVA was employed to assess differences in 
plasma [NO2-], V̇O2 kinetics, SpO2, TOI and exercise tolerance across the 
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experimental conditions.  Significant effects were further explored using post-
hoc Fisher’s LSD t-tests. Relationships between the outcome variables were 
assessed using Pearson’s correlation coefficient (r). Statistical analyses were 
performed using SPSS version 23.0 (IBM, Chicago, USA) with significance 
accepted when P<0.05. Data are presented as mean ± SD, unless stated 
otherwise. 
 
Results  
 
The BR and PL supplements and hypoxic and hyperoxic inspirates 
administered in this study were well tolerated with no side-effects reported. All 
participants self-reported that their dietary and exercise habits were consistent 
across the duration of the study. Participants attained a peak work rate of 379 ± 
40 W and V̇O2 of 3.82 ± 0.50 L·min-1 (49 ± 5 ml·kg-1·min-1) during the ramp 
incremental test. The work rates applied during the moderate-intensity and 
severe-intensity step cycle tests were 106 ± 14 and 292 ± 34 W, respectively. 
 
Plasma [nitrite]  
 
Plasma [NO2-] data are presented in Figure 1. Plasma [NO2-] was higher at the 
end of baseline cycling, moderate-intensity cycling, 120 sec of severe-intensity 
cycling and at exhaustion in the BR-Hypo (410 ± 220, 385 ± 212, 334 ± 216 and 
231 ± 130 nM, respectively), BR-Norm (398 ± 191, 368 ± 130, 390 ± 147 and 
246 ± 77 nM, respectively) and BR-Hyper (359 ± 104, 343 ± 88, 369 ± 113 and 
247 ± 74 nM, respectively) trials compared to the PL-Hypo (107 ± 92, 97 ± 87, 
110 ± 82 and 99 ± 80 nM, respectively), PL-Norm (89 ± 44, 91 ± 42, 85 ± 27 
and 80 ± 32 nM, respectively) and PL-Hyper (89 ± 40, 82 ± 37, 61 ± 24 and 59 ± 
19 nM, respectively) trials (P<0.01); however, there were no differences 
between the BR-Hypo, BR-Norm and BR-Hyper trials or between the PL-Hypo, 
PL-Norm and PL-Hyper trials at specific time points (P>0.05). In the BR, but not 
PL trials, plasma [NO2-] was lower at exhaustion compared to the end of 
baseline cycling, moderate-intensity cycling and 120 sec of severe-intensity 
cycling (P<0.05). 
65 
 
 
 
Figure 1. Plasma nitrite concentration ([NO2-]) following nitrate-depleted beetroot juice (PL) in 
hypoxia (PL-Hypo), normoxia (PL-Norm) and hyperoxia (PL-Hyper), and following nitrate-rich 
beetroot juice (BR) in hypoxia (BR-Hypo), normoxia (BR-Norm) and hyperoxia (BR-Hyper). 
Plasma was sampled at the end of unloaded baseline cycling at 20 W, moderate-intensity 
cycling, 120 sec of severe-intensity cycling and at the point of exhaustion during severe-
intensity cycling. Data are presented as group mean ± SEM. * indicates BR-Hypo, BR-Norm, 
and BR-Hyper trials are higher than PL-Hypo and PL-Norm and PL-Hyper (P<0.05). # indicates 
different from baseline, end moderate and 120 sec severe in the BR-Hypo, BR-Norm, and BR-
Hyper trials (P<0.05). 
 
Arterial oxygen saturation 
 
The mean SpO2 data are presented in Figure 2. Mean SpO2 was lower in the 
hypoxic trials compared to the normoxic and hyperoxic trials (P<0.01), but not 
different between the normoxic and hyperoxic trials (P>0.05).   
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Figure 2. Arterial oxygen saturation (SpO2) following nitrate-depleted beetroot juice (PL) in 
hypoxia (PL-Hypo), normoxia (PL-Norm) and hyperoxia (PL-Hyper), and following nitrate-rich 
beetroot juice (BR) in hypoxia (BR-Hypo), normoxia (BR-Norm) and hyperoxia (BR-Hyper). The 
open bars represent the group mean ± SEM SpO2 from the PL trials while the filled bars 
represent the group mean ± SEM SpO2 from the BR trials. Data represent the mean SpO2 up 
120 sec of severe-intensity cycling exercise. * indicates different from PL-Hypo and BR-Hypo 
(P<0.05).   
 
Tissue oxygenation index 
 
Quadriceps TOI data are presented in Figure 3. Quadriceps TOI was higher 
during moderate-intensity and severe-intensity cycling exercise in the PL-Norm 
trial compared to the PL-Hypo trial (P<0.05) and in the PL-Hyper trial compared 
to the PL-Hypo and PL-Norm trials (P<0.05; Figure 3). There were no 
differences in quadriceps TOI between the PL-Hypo and BR-Hypo trials or 
between the PL-Hyper and BR-Hyper trials (P>0.05), but quadriceps TOI was 
higher during baseline (71 ± 3 vs. 69 ± 3 %) and at moderate-intensity (67 ± 5 
vs. 65 ± 4 %) cycling exercise in the BR-Norm trial compared to the PL-Norm 
trial (P<0.05; Figure 4).   
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Figure 3. Quadriceps tissue oxygenation index (TOI) responses following nitrate-depleted 
beetroot juice (PL) in hypoxia (PL-Hypo), normoxia (PL-Norm) and hyperoxia (PL-Hyper). TOI 
data during baseline cycling at 20 W (-60-0 sec), moderate-intensity cycling (0-240 sec) and 
severe-intensity cycling (240-360 sec) are group mean responses displayed as 5 sec averages. 
TOI data at exhaustion during severe-intensity cycling exercise represent the mean TOI over the 
final 60 sec of exercise and are presented as group mean ± SEM. # indicates different from PL-
Hypo and BR-Hypo (P<0.05). * indicates different from PL-Norm, BR-Norm, PL-Hypo and BR-
Hypo (P<0.05).   
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Figure 4. Quadriceps tissue oxygenation index (TOI) responses following nitrate-depleted 
beetroot juice (PL) and nitrate-rich beetroot juice (BR) in hypoxia (upper panel; PL-Hypo and 
BR-Hypo, respectively), normoxia (middle panel; PL-Norm and BR-Norm, respectively) and 
hyperoxia (lower panel; PL-Hyper and BR-Hyper, respectively). TOI data during baseline cycling 
at 20 W (-60-0 sec), moderate-intensity cycling (0-240 sec) and severe-intensity cycling (240-
360 sec) are group mean responses displayed as 5 sec averages. TOI data at exhaustion 
during severe-intensity cycling exercise represent the mean TOI over the final 60 sec of 
exercise and are presented as group mean ± SEM. * indicates different from PL-Hypo (P<0.05). 
# indicates different from PL-Norm (P<0.05).    
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Pulmonary oxygen uptake kinetics 
 
The group mean pulmonary V̇O2 data are presented in Table 1 with the V̇O2 
responses from a representative individual and the group mean end-exercise 
V̇O2 shown in Figure 5. There were no differences in the absolute V̇O2 during 
baseline, moderate-intensity cycling or the first 180 sec of severe-intensity 
cycling between any of the experimental conditions (P>0.05). The V̇O2 MRT 
was longer following the onset of severe-intensity cycling initiated from a 
moderate-intensity baseline compared to moderate-intensity cycling initiated 
from an unloaded baseline (P<0.01; Table 1). However, the V̇O2 MRT during 
moderate-intensity and severe-intensity exercise were not different between 
experimental conditions (P>0.05). The change in V̇O2 over the first 180 sec of 
severe-intensity cycling and end-exercise V̇O2 during severe-intensity cycling 
were not different between the PL-Norm and PL-Hyper conditions (P>0.05) but 
were lower in the PL-Hypo trial compared to both the PL-Norm and PL-Hyper 
trials (P<0.05; Table 1). There were no differences in the change in V̇O2 over 
the first 180 sec or end-exercise V̇O2 during severe-intensity cycling between 
the BR and PL conditions in normoxia and hyperoxia (P>0.05), but these 
variables were both higher after BR supplementation in hypoxia compared to PL 
supplementation in hypoxia (P<0.05; Table 1; Figure 5).    
 
Table 1. Pulmonary oxygen uptake kinetics following a step increment in work rate from 
unloaded to moderate-intensity cycling and moderate-intensity to severe-intensity 
cycling after nitrate-rich and nitrate-depleted beetroot juice in hypoxia, normoxia and 
hyperoxia. 
 PL-Hypo BR-Hypo PL-Norm BR-Norm PL-Hyper BR-Hyper 
 U→M 
Baseline V̇O2 (L·min
-1) 
0.90 ± 
0.14 
0.87 ± 
0.09 
0.89 ± 
0.09 
0.89 ± 
0.12 
0.86 ± 
0.09 
0.90 ± 
0.20 
End V̇O2 (L·min
-1) 
1.65 ± 
0.23 
1.60 ± 
0.20 
1.64 ± 
0.20 
1.61 ± 
0.22 
1.62 ± 
0.16 
1.60 ± 
0.25 
∆ End-Baseline V̇O2 
(L·min-1) 
0.75 ± 
0.11 
0.72 ± 
0.14 
0.75 ± 
0.16 
0.72 ± 
0.13 
0.76 ± 
0.15 
0.69 ± 
0.12 
Mean response time 
(sec) 
49 ± 15 39 ± 10 43 ± 9 47 ± 13 41 ± 14 41 ± 9 
 M→S 
Baseline V̇O2 (L·min
-1) 
1.65 ± 
0.23 
1.60 ± 
0.20 
1.64 ± 
0.20 
1.61 ± 
0.22 
1.62 ± 
0.16 
1.60 ± 
0.25 
180 sec V̇O2 (L·min
-1) 
3.27 ± 
0.35 
3.35 ± 
0.42 
3.46 ± 
0.47 
3.49 ± 
0.46 
3.48 ± 
0.25 
3.40 ± 
0.48 
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∆ 180 sec-Baseline V̇O2 
(L·min-1) 
1.62 ± 
0.22 
1.75 ± 
0.24¥ 
1.81 ± 
0.27# 
1.88 ± 
0.30# 
1.86 ± 
0.14# 
1.80 ± 
0.25# 
Mean response time 
(sec) 
64 ± 17* 62 ± 13* 68 ± 11* 67 ± 11* 61 ± 17* 60 ± 16* 
End V̇O2 (L·min
-1) 
3.28 ± 
0.33 
3.43 ± 
0.36¥ 
3.82 ± 
0.53# 
3.83 ± 
0.44# 
3.82 ± 
0.35# 
3.82 ± 
0.58# 
∆ End-Baseline V̇O2 
(L·min-1) 
1.64 ± 
0.20 
1.83 ± 
0.21¥ 
2.18 ± 
0.35# 
2.21 ± 
0.29# 
2.20 ± 
0.30# 
2.22 ± 
0.39# 
Data are presented as mean ± SD. PL-Hypo, acute ingestion of a nitrate-depleted beetroot juice 
concentrate and inhalation of a hypoxic inspirate; BR-Hypo, acute ingestion of a nitrate-rich 
beetroot juice concentrate and inhalation of a hypoxic inspirate; PL-Norm, acute ingestion of a 
nitrate-depleted beetroot juice concentrate and inhalation of a normoxic inspirate; BR-Norm, 
acute ingestion of a nitrate-rich beetroot juice concentrate and inhalation of a normoxic 
inspirate; PL-Hyper, acute ingestion of a nitrate-depleted beetroot juice concentrate and 
inhalation of a hyperoxic inspirate; BR-Hyper, acute ingestion of a nitrate-rich beetroot juice 
concentrate and inhalation of a hyperoxic inspirate; U→M, a step increment from an unloaded 
baseline to a moderate-intensity work rate; M→S, a step increment from a moderate-intensity 
baseline work rate to a severe-intensity work rate; V̇O2, pulmonary oxygen uptake; ∆, difference; 
* different from U→M value (P<0.05); # different from PL-Hypo and BR-Hypo (P<0.05); ¥ 
different from PL-Hypo (P<0.05). 
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Figure 5. Pulmonary oxygen uptake (V̇O2) responses following nitrate-depleted beetroot juice 
(PL) and nitrate-rich beetroot juice (BR) in hypoxia (upper panel; PL-Hypo and BR-Hypo, 
respectively), normoxia (middle panel; PL-Norm and BR-Norm, respectively) and hyperoxia 
(lower panel; PL-Hyper and BR-Hyper, respectively). V̇O2 data during unloaded baseline cycling 
at 20 W (-60-0 sec), moderate-intensity cycling (0-240 sec) and severe-intensity cycling (240-
360 sec) are displayed as 5 sec averages from a representative subject. Insets present end-
exercise V̇O2 (mean over the final 60 sec of severe-intensity cycling) following PL and BR 
supplementation in hypoxia, normoxia and hyperoxia. The open bars represent the group mean 
± SEM end-exercise V̇O2 in the PL trials, while the filled bars represent the group mean ± SEM 
plasma end-exercise V̇O2 in the BR trials. The solid grey lines represent the individual changes 
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in end-exercise V̇O2 following BR supplementation at a given fraction of inspired O2. * indicates 
different from PL-Hypo (P<0.05). 
 
Exercise tolerance 
 
Tlim was lower in the normoxic trials (PL-Norm: 344 ± 78 sec; BR-Norm: 364 ± 
98 sec) compared to the hyperoxic trials (PL-Hyper: 472 ± 196 sec; BR-Hyper: 
492 ± 212 sec) and lower in the hypoxic trials (PL-Hypo: 231 ± 41 sec; BR-
Hypo: 250 ± 44 sec) compared to the normoxic and hyperoxic trials (P<0.05; 
Figure 6). Tlim was not different between BR and PL in the hyperoxic trials 
(P>0.05), tended to be higher with BR in the normoxic trials (P=0.087) and was 
increased with BR in the hypoxic trials (P<0.05; Figure 6). The improved 
exercise tolerance after BR supplementation in hypoxia was negatively 
correlated with the end-exercise quadriceps TOI in the PL-Hypo trial (r = -0.78, 
P<0.05; Figure 7).  
 
 
Figure 6. Time to exhaustion (Tlim) following nitrate-depleted beetroot juice (PL) in hypoxia (PL-
Hypo), normoxia (PL-Norm) and hyperoxia (PL-Hyper), and following nitrate-rich beetroot juice 
(BR) in hypoxia (BR-Hypo), normoxia (BR-Norm) and hyperoxia (BR-Hyper). The open bars 
represent the group mean ± SEM Tlim from the PL trials while the filled bars represent the group 
mean ± SEM Tlim from the BR trials. The solid grey lines represent the individual changes in T lim 
following BR supplementation at a given fraction of inspired O2. * indicates different from PL-
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Hypo (P<0.05). # indicates different from PL-Hypo and BR-Hypo (P<0.05). ¥ indicates different 
from PL-Norm, BR-Norm, PL-Hypo and BR-Hypo (P<0.05). 
 
 
Figure 7. The relationship between end-exercise tissue oxygenation index (TOI; mean over the 
final 60 sec of severe-intensity cycling) following nitrate-depleted beetroot juice (PL) in hypoxia 
(PL-Hypo) and the change (Δ) in time to exhaustion (T lim) between the PL and nitrate-rich 
beetroot juice (BR) trials in hypoxia (PL-Hypo and BR-Hypo, respectively). Note that end-
exercise TOI in PL-Hypo was negatively correlated with Δ Tlim between the PL-Hypo and BR-
Hypo trials.  
 
Discussion 
 
This study investigated how dietary NO3- supplementation influenced muscle 
oxygenation, V̇O2 kinetics and exercise tolerance in hypoxia, normoxia and 
hyperoxia. Plasma [NO2-] was increased in all BR compared to all PL trials but 
was not influenced by the FiO2 at rest, during exercise or at exhaustion. Multi-
channel NIRS-derived quadriceps TOI was positively associated with the FiO2 
and was higher during baseline and moderate-intensity cycling exercise in 
normoxia following BR supplementation. T lim was increased in hypoxia, with the 
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magnitude of improvement being negatively correlated with quadriceps TOI at 
exhaustion, tended to be improved in normoxia and remained unaltered in 
hyperoxia following BR supplementation. Peak V̇O2 was greater following BR 
supplementation in hypoxia but remained unaltered in normoxia and hyperoxia. 
These findings suggest that the potential for dietary NO3- supplementation to 
improve the physiological responses and tolerance to exercise is greater as 
skeletal muscle becomes increasingly hypoxic.  
 
Plasma [nitrite] 
 
Consistent with previous research (Bailey et al., 2009; 2010; Vanhatalo et al., 
2010; 2011; Webb et al., 2008; Wylie et al., 2013), plasma [NO2-] was increased 
in all BR compared to all PL trials. The increment in plasma [NO2-] due to BR 
supplementation was not significantly different at baseline between hypoxia 
(347 ± 157 nM), normoxia (299 ± 147 nM) and hyperoxia (270 ± 64 nM) and 
plasma [NO2-] remained unaltered after 4 min of moderate-intensity and 2 min 
of severe-intensity exercise in all conditions. At exhaustion, plasma [NO2-] was 
lowered in each of the BR trials. This is likely due to an elevated rate of NO2- 
reduction to NO, which is facilitated in hypoxia and acidosis (Lundberg and 
Govoni, 2004); conditions that might be evident in contracting skeletal muscle 
(Bailey et al., 2010; Richardson et al., 1999). No additional influence was 
observed due to the FiO2 at exhaustion. Similar [NO2-] kinetics were reported by 
Kelly et al., (2014) who investigated the variations between hypoxia and 
normoxia. However, the authors observed a significant reduction in plasma 
[NO2-] after 1 min of severe-intensity exercise in hypoxia following BR 
supplementation which was not evident in the present study. This might be 
explained by the larger NO3- dose (19.5 mmol) administered herein.  
 
Influence of fraction of inspired oxygen on arterial and muscle oxygenation 
 
Administration of the hypoxic (15% O2), normoxic (21% O2) and hyperoxic (40% 
O2) inspirates influenced arterial SpO2 and quadriceps TOI. SpO2 was lower in 
hypoxia (88 ± 4%) than in normoxia (95 ± 3%) but was not different between 
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normoxia and hyperoxia (95 ± 6%). These changes in SpO2 would be expected 
to impact upon the O2 diffusion cascade, therefore, altering muscle oxygenation 
during exercise. Consequently, TOI was higher during moderate- (65 ± 4 vs. 64 
± 4%) and severe- (54 ± 6 vs. 51 ± 7%) intensity exercise in normoxia 
compared to hypoxia, and was greater still during moderate- (67 ± 5%) and 
severe- (56 ± 7%) intensity exercise in hyperoxia.  
 
Influence of nitrate-rich beetroot juice supplementation on the physiological 
responses to moderate-intensity exercise 
 
Acute BR supplementation had no effect on pulmonary V̇O2 but did influence 
quadriceps TOI, as investigated using multi-channel NIRS, during moderate-
intensity exercise in normoxia. The unaltered V̇O2 is consistent with the 
observations of Breese et al., (2013) who employed a work-to-work step cycling 
exercise protocol, with a moderate-intensity bout that also lasted for 4 min, and 
a chronic BR supplementation procedure (providing ~8 mmol.day-1 NO3- for 6 
days). However, reductions in sub-maximal V̇O2 have previously been reported 
following a single step transition cycling bout lasting for 5-6 min and both a 
chronic (providing ~11 mmol.day-1 NO3- for 6 days; 5% reduction in V̇O2; Bailey 
et al., 2009) and acute (providing 16.8 mmol NO3-; 3% reduction in V̇O2; Wylie 
et al., 2013) BR supplementation procedure. These discrepancies might be 
explained by the duration of the exercise protocol, such that the 4 min bout 
employed in the present study might not have been sufficient to detect a change 
in V̇O2. An extended duration was prevented due to the further step increment 
that was completed until the limit of tolerance and the possibility of this resulting 
in the 1000 L capacity of the Douglas bag being reached. This was a limitation 
of the present study and, consequently, is an area for further research. Also, 
chronic, rather than acute, BR supplementation might have been more effective. 
Despite the unaltered V̇O2, TOI was higher during baseline (71 ± 3 vs. 69 ± 3 
%) and moderate-intensity (67 ± 5 vs. 65 ± 4 %) cycling exercise, indicating an 
improved muscle oxygenation (Ferrari, Mottola and Quaresima, 2004). This 
finding builds upon the single-channel work of Bailey et al., (2009), who 
observed an increased total [haemoglobin] and [oxyhaemoglobin], signifying an 
increased muscle O2 delivery, and a reduced [deoxyhaemoglobin], signifying a 
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reduced muscle O2 extraction, in the vastus lateralis during moderate-intensity 
exercise. This physiological response is explained by the Fick equation which 
states that for the same V̇O2 an increased muscle O2 delivery allows for a 
reduced muscle O2 extraction. An increased muscle O2 delivery following 
dietary NO3- consumption is presumably the result of greater vasodilation, 
caused by increased NO2- reduction to NO.  
 Acute BR supplementation had no effect on pulmonary V̇O2 and 
quadriceps TOI in hypoxia or hyperoxia. Hypoxia is associated with increased 
NO2- reduction to NO (Bryan, 2006) whereas the combination of hypoxia and 
muscular contraction is known to create a strong stimulus for vasodilation to 
ensure sufficient muscle O2 delivery (Calbet et al., 2009; Casey et al., 2010). 
Subsequent research has demonstrated a reduced V̇O2 during baseline (10%) 
and moderate-intensity (7%) cycling exercise in hypoxia with a trend towards an 
improved vastus lateralis TOI (3.6%) following BR supplementation (providing 
8.4 mmol.day-1 NO3- for 3 days; Kelly et al., 2014). The contradictory findings 
observed in the present study might be explained by the variation in 
supplementation procedure employed, such that the acute dose of BR 
administered might not have been sufficient to elicit a change in V̇O2 or TOI. In 
hyperoxia, the unaltered V̇O2 and TOI observed following BR supplementation, 
which was investigated for the first time in this study, suggests that O2 
availability to the active musculature was sufficient prior to dietary NO3- 
consumption to meet the demands for oxidative energy turnover during 
moderate-intensity exercise with this FiO2. This observation supports previous 
research which demonstrated that O2 delivery to the active musculature is 
greater than utilisation during submaximal exercise in hyperoxia (Evans et al., 
2001). 
 
Influence of nitrate-rich beetroot juice supplementation on the physiological 
responses and tolerance to severe-intensity exercise 
 
Acute BR supplementation had no effect on quadriceps TOI but did 
influence pulmonary V̇O2 and exercise tolerance during severe-intensity 
exercise in hypoxia. Tlim was improved by 8%, while the change in V̇O2 over the 
first 180 sec of severe-intensity cycling exercise was increased by 8%, end-
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exercise V̇O2 was increased by 4% and TOI remained unaltered. The elevated 
V̇O2 suggests that muscle O2 delivery was increased following dietary NO3- 
consumption, which would be expected to enhance oxidative energy production. 
This would then spare the finite anaerobic reserves (i.e. phosphocreatine and 
glycogen), thus delaying the development of local muscle fatigue and 
prolonging exercise tolerance (Vanhatalo et al., 2011). Furthermore, the strong, 
negative correlation between the change in Tlim due to BR supplementation and 
end-exercise TOI following PL supplementation shows that participants with a 
lower muscle oxygenation status at the limit of tolerance had a greater 
ergogenic effect from dietary NO3- consumption. A lower oxygenation status 
would be accompanied by an increased O2 pressure gradient between the 
contracting myocytes and the surrounding capillaries. This would likely stimulate 
local NO2- reduction to NO and, subsequently, NO-mediated vasodilation, thus 
elevating muscle O2 delivery. The increased availability of O2 would then allow 
for greater oxidative energy production, culminating in a prolonged tolerable 
duration of exercise. The magnitude of increment in T lim following BR 
supplementation is similar to that reported previously by Kelly et al., (2014; 9%) 
and might translate to a ~1% improvement in athletic performance when using 
an ecologically valid test, such as a cycling time-trial (Paton and Hopkins, 
2006). Therefore, BR supplementation might have ergogenic potential for 
athletes who experience a reduced skeletal muscle oxygenation status when 
performing at altitude. 
 Acute BR supplementation tended to improve exercise tolerance, while 
pulmonary V̇O2 and quadriceps TOI remained unaltered, in normoxia and had 
no effect in hyperoxia. In normoxia, T lim was non-significantly improved by 5% 
which contradicts the 22% improvement reported by Breese et al., (2013), who 
also used the work-to-work step cycling exercise protocol. This discrepancy 
might be explained by the variation in supplementation procedures employed by 
the two studies. In hyperoxia, the unaltered T lim builds upon previous research 
that demonstrated a reduced time to fatigue in intact mouse muscle fibres 
following incubation with sodium NO2- at a supra-physiological PO2 (Nogueira et 
al., 2013). However, the 40% O2 inspirate used in the present study is less than 
that administered by Nogueira et al., 2013. Therefore, further research is 
required to investigate how dietary NO3- supplementation influences muscle 
78 
 
oxygenation, V̇O2 kinetics and exercise tolerance when inhaling 100% O2. The 
unaltered V̇O2 and TOI might be explained by previous observations that 
hyperoxia is associated with an increased muscle O2 delivery (Astorino and 
Robergs, 2003) and greater maintenance of muscle contractile function 
(Linossier et al., 2000) during maximal exercise; physiological responses that 
are consistent with those induced by dietary NO3- supplementation in hypoxia. 
This would be expected to attenuate the stimulus for local NO2- reduction to NO 
and provides a possible explanation for the lack of effect observed following BR 
supplementation in hyperoxia.  
 
Conclusion 
 
Plasma [NO2-] was increased by acute BR supplementation but was not 
different between hypoxia, normoxia or hyperoxia at rest, during exercise or at 
exhaustion. Multi-channel, NIRS-derived, quadriceps TOI was higher, while 
pulmonary V̇O2 remained unaltered, during baseline and moderate-intensity 
cycling exercise in normoxia following BR supplementation, which suggests an 
elevated muscle oxygenation consequent to an enhanced NO-mediated 
vasodilation. Tlim, the change in V̇O2 over the first 180 sec and end-exercise 
V̇O2 were all increased, while TOI remained unaltered, during severe-intensity 
exercise in hypoxia following BR supplementation. This is indicative of an 
increased muscle O2 delivery which might have increased oxidative energy 
production, thus sparing the finite anaerobic reserves and improving exercise 
tolerance. Tlim tended to be increased in normoxia but was unaltered in 
hyperoxia following BR supplementation. These findings extend our 
understanding of the effect of dietary NO3- supplementation on muscle 
oxygenation, V̇O2 kinetics and exercise tolerance in hypoxia, normoxia and 
hyperoxia.  
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Chapter 5: General discussion 
 
The aim of this thesis was to enhance existing knowledge of the conditions that 
might influence the efficacy of dietary NO3- supplementation to improve exercise 
physiology and performance. To achieve this, two studies were performed 
independently to explore the reduction of NO3- to NO2- and NO2- to NO, 
respectively. These studies addressed the following research questions:   
 
1) Does the manipulation of oral cavity temperature and pH influence the 
effectiveness of BR supplementation at increasing NO bioavailability in 
humans? 
 
3) Does altering the FiO2 influence the effectiveness of BR supplementation 
at improving the physiological responses and tolerance to exercise? 
 
Summary of findings  
Influence of oral temperature and pH on dietary nitrate metabolism in healthy 
adults 
 
In chapter 3, the influence of oral cavity temperature and pH manipulation on 
the effectiveness of BR supplementation at increasing NO bioavailability was 
investigated for the first time. Salivary and plasma [NO3-] and [NO2-] were all 
increased following BR supplementation. Salivary [NO2-] was increased further 
when oral temperature and pH were elevated independently (41 and 90%, 
respectively) and concurrently (84%), however, the peak increase (116%) was 
evident when oral temperature was lowered (34°C) and oral pH was elevated 
(7.9). Plasma [NO2-] was also increased further 3 hours post BR consumption in 
the alkaline pH conditions.  
 
Effect of dietary nitrate supplementation on oxygen uptake kinetics and exercise 
tolerance: influence of muscle oxygenation 
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In chapter 4, the influence of BR supplementation on muscle oxygenation, V̇O2 
kinetics and exercise tolerance in hypoxia, normoxia and hyperoxia was 
investigated. Plasma [NO2-] was increased following BR supplementation but 
was not influenced by FiO2 at rest, during exercise or at exhaustion. Multi-
channel NIRS-derived quadriceps TOI was positively associated with the FiO2 
and was higher during baseline (3%) and moderate-intensity (3%) cycling 
exercise in normoxia following BR supplementation. Tlim was increased (8%) in 
hypoxia, with the magnitude of improvement being negatively correlated with 
quadriceps TOI at exhaustion, tended to be improved (5%) in normoxia and 
remained unaltered in hyperoxia following BR supplementation. Peak V̇O2 was 
greater (4%) following BR supplementation in hypoxia but remained unaltered in 
normoxia and hyperoxia. 
 
Nitric oxide bioavailability  
 
Consistent with previous research, the evidence in chapters 3 and 4 
demonstrates that dietary NO3- supplementation with BR increases salivary 
[NO3-] and [NO2-] (McDonagh et al., 2015; Woessner et al., 2016) and plasma 
[NO3-] (McDonagh et al., 2015; Wylie et al., 2013) and [NO2-] (Bailey et al., 
2009; 2010; Vanhatalo et al., 2010; 2011; Webb et al., 2008; Wylie et al., 2013). 
This suggests that NO bioavailability would also be greater following BR 
supplementation. The increase in resting plasma [NO2-] occurred following ~6.5 
(142 nM; chapter 3) and ~19.5 (388 nM; chapter 4) mmol NO3- consumption, 
which identifies that the magnitude of improvement is determined by the dose of 
NO3- consumed. This finding supports the work of Wylie et al., (2013) who 
demonstrated dose-dependent increases in plasma [NO2-] following acute BR 
supplementation with 4.2, 8.4 and 16.8 mmol NO3-. The dietary NO3- doses 
used in chapters 3 and 4 were selected based on previous research which 
demonstrated that a larger dose is required to elicit improvements in exercise 
economy and tolerance compared to plasma and salivary [NO3-] and [NO2-] 
(McDonagh et al., 2015; Wylie et al., 2013). In chapter 3, the increase in resting 
salivary and plasma [NO3-] and [NO2-], and the delayed time to peak plasma 
[NO2-], following BR supplementation highlights the importance of dietary NO3- 
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on the enterosalivary circuit and, therefore, the metabolism of NO3- by 
commensal oral bacteria (Duncan et al., 1995; Sasaki and Matano, 1979; 
Spiegelhalder, Eisenbrand and Preussmann, 1976).  
 
Factors influencing dietary nitrate metabolism 
Oral cavity temperature and pH 
 
Salivary and plasma [NO3-] remained unaltered following acute dietary NO3- 
supplementation with BR and oral temperature and pH manipulation. Salivary 
[NO2-] was increased further in the independently (TempMid-pHHi: 90%; TempHi-
pHNorm: 41%) and concurrently (TempHi-pHHi: 84%) elevated oral temperature 
and pH conditions and in the low oral temperature conditions (TempLo-pHNorm: 
53% TempLo-pHHi: 106%) compared to the TempMid-pHNorm trial. Plasma [NO2-] 
was increased further than the TempMid-pHNorm trial in the independently 
elevated oral pH condition (TempMid-pHHi: 20%), the concurrently elevated oral 
temperature and pH condition (TempHi-pHHi: 53%) and in the TempLo-pHHi trial 
(37%). This evidence indicates that dietary NO3- metabolism is influenced by 
oral cavity temperature and pH and builds upon previous research that 
demonstrated an increased [NO2-] following both NO3- consumption and oral pH 
manipulation using a pH-regulating chewing gum (van Maanen, van Geel and 
Kleinjans, 1996) and the incubation of an alkaline NO3- test solution in the 
mouth (Bojić, Bojić and Pervović, 2004).  
 
Muscle oxygenation 
 
In chapter 4, the increased plasma [NO2-] observed following acute dietary NO3- 
supplementation with BR was not significantly influenced by the FiO2 at rest, 
during ‘work-to-work step’ cycling exercise to moderate- and severe-intensity 
constant work rates or at exhaustion. This evidence indicates that muscle 
oxygenation does not influence dietary NO3- metabolism and builds upon 
previous research, that demonstrated no variation in plasma [NO2-] kinetics 
between normoxia and hypoxia (Kelly et al., 2014), by showing, for the first 
time, that a similar effect is apparent in hyperoxia.  
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Applications  
 
The studies in this thesis provide evidence that dietary NO3- supplementation 
increases the potential for O2- and NOS-independent NO generation in healthy 
young adults. Increased NO bioavailability has previously been associated with 
a number of physiological benefits and ergogenic effects. For example, dietary 
NO3- consumption has been reported to lower systolic blood pressure at rest, 
reduce pulmonary V̇O2 and muscle fractional O2 extraction during moderate-
intensity exercise and to improve tolerance to severe-intensity exercise (Bailey 
et al., 2009). 
In chapter 3, the elevated salivary and plasma [NO2-] demonstrated 
following acute BR supplementation and oral temperature and pH manipulation 
might have implications for future BR supplementation recommendations, might 
contribute to understanding of the underlying physiology for responders and 
non-responders to dietary NO3- supplementation, and might enhance the 
cardiovascular health and physical performance benefits demonstrated at a 
given dietary NO3- dose.  
In chapter 4, the improved Tlim in hypoxia following acute BR 
supplementation might be of interest to athletes and coaches involved in short-
duration, severe-intensity cycling exercise performed at moderate altitude. BR 
supplementation was demonstrated to be particularly effective for individuals 
who experience a reduced skeletal muscle oxygenation status when performing 
in hypoxia. The development of specific pre-competition nutritional plans 
involving the consumption of dietary NO3- might improve athletic performance.  
 
Limitations and directions for future research 
 
Despite the same dietary NO3- dose being consumed in chapter 3, the 
increases in salivary and plasma [NO2-] varied depending on the temperature 
and pH of the oral cavity. The greatest increase in salivary [NO2-] was observed 
in the TempLo-pHHi trial. This was attributed to an elevated salivary flow rate 
which would likely result in greater NO3- secretion by the salivary glands thus 
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providing more substrate for reduction to NO2-. However, despite the larger 
salivary [NO2-] in the TempLo-pHHi trial, the greatest increase in plasma [NO2-] 
occurred in the TempHi-pHHi trial. It was suggested that this measurement might 
have been confounded by the mouth rinse protocol, which resulted in 46% more 
NO2--rich saliva being expectorated following the mouth rinses and sample 
collections in the TempLo-pHHi trial compared to the TempHi-pHHi trial. This 
would likely impair the characteristic rise in plasma [NO2-] demonstrated 
following dietary NO3- supplementation (Lundberg and Govoni, 2004; Webb et 
al., 2008). Furthermore, the oral temperature manipulation might have elevated 
core temperature, which is known to increase endothelial NOS activity and NO 
release (Harris et al., 2003). This would be expected to increase plasma [NO2-] 
independently of dietary NO3- metabolism. Future research should build upon 
these limitations by controlling for potential confounding factors when 
investigating the factors that influence dietary NO3- metabolism.  
 
Conclusion 
 
Investigation of the cardiovascular health and physical performance benefits of 
dietary NO3- supplementation is a current hot topic in nutrition. This thesis 
aimed to contribute to the available literature by investigating the factors that 
influence dietary NO3- metabolism in humans. The collected data suggests that 
oral cavity temperature and pH manipulation influences dietary NO3- 
metabolism in humans and that the performance benefit of NO3- 
supplementation is influenced by muscle oxygenation.  
The study in chapter 3 demonstrates, for the first time, that salivary [NO2-
] following acute BR supplementation is elevated by a decreased oral 
temperature and an increased oral pH. This finding might have implications for 
enhancing some of the beneficial effects of dietary NO3- supplementation on 
human cardiovascular health and physical performance. The study in chapter 4 
demonstrates that severe-intensity exercise tolerance is improved to a greater 
extent as skeletal muscle becomes increasingly hypoxic. This finding suggests 
that acute BR supplementation might have applications as an ergogenic aid for 
the performance of short-duration, severe-intensity cycling exercise in moderate 
hypoxia. 
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